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Previous studies have shown that mitochondrial petites of 
the yeast Saccharomyces cerevisiae appear to have some 
advantage over their wild type counterparts in terms of 
fermentative performance.
In this thesis evidence is presented that inhibition of the 
respiratory chain by chemical or genetic means leads to an 
increase in ethanol formed per unit sugar and a decrease in 
biomass per unit sugar. The genetic studies involve a 
mutation in formation of subunit III of the cytochrome £  
oxidase complex (pet!22) and a mutation in putative 
mitochondrial pyruvate transport (tpyl). The chemical study 
involves inhibition of mitochondrial pyruvate transport by a 
specific inhibitor alpha-cyano-4-hydroxycinnamic acid.
To try and discover more of the nature of the tpyl mutation 
a gene was cloned from a yeast centromeric genomic library 
which complemented the mutation. The insert containing the 
complementing gene was reduced in size and sequenced. An 
open reading frame containing 1698 nucleotides coding for 
566 amino acids was discovered. After comparison to 
databases the gene appeared to be undiscovered to date. No 
similarity was found between the translated protein and 
others on databases with the exception of the FAS2 gene of 
Penicillium patulum.
Studies of isolated mitochondria and cell growth pattern, of 
the tpyl mutant, revealed data typical of a classical petite 
mutation rather than a mutation in a regulatory gene as 
described by the original paper describing the mutant.
Work presented in this thesis has been included, or is to be 
included in the following publications;
Hill J, Donald K.A.G. and Griffiths D.E., DMSO-enhanced 
whole cell yeast transformation, (1991). Nucl. Acid Res., 
19. 5791
Donald K.A.G.,H111 J and Griffiths D.E., Cloning and 
Sequencing of a gene complementing the petite like mutation 
tpyl in Saccharomyces cerevisiae, in preparation
The DNA sequence of the TPY1 gene has been submitted to the 
EMBL DNA database. The accession number is X62A30.
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1INTRODUCTION
Many yeasts are facultative anaerobes, that is as well as 
having the ability to respire in the presence of oxygen they 
are also able to survive in its absence. In the presence of 
oxygen yeasts can oxidise sugars to carbon dioxide and water 
and in its absence some yeasts can ferment sugars to carbon 
dioxide and ethanol.
Saccharomyces cerevisiae is a yeast which has been used for 
centuries in the processes of baking (aerobic respiration) 
and alcoholic fermentation (anaerobic respiration) with 
little knowledge of biochemical principles involved. However 
over the last century studies have revealed much of this 
yeast's complex machinery. During the last twenty years or 
so S.cerevisiae has become an important tool in genetic 
studies and is perhaps second only to Escherichia coli in 
this field.
1.1 The Biochemistry of Yeast Fermentation
In order to utilize the energy contained in sugars external 
to S.cerevisiae the sugars must be either digested 
externally and then be imported or they may be imported 
directly. Either way once inside the cell the energy the 
sugars contain is released slowly in a stepwise process. The 
metabolic pathway from the entry of the sugar to the 
formation of pyruvate is known as glycolysis. In
2S.cerevisiae glucose, fructose and galactose are taken up by 
facilitated diffusion (Heredia et al 1968) whereas maltose 
is imported by proton co-transport (Serrano 1977) and 
sucrose is digested extracellularly to glucose and fructose. 
The principle sugars occurring in brewers wort are maltose 
(approximately 6%) and glucose (approximately IX) 
(Lancashire personal communication). Once inside the cell 
the sugar is broken down to a monosaccharide, if it is not 
already one, and phosphorylated by the appropriate kinase at 
the expense of ATP.
Glucose 6-phosphate is converted to fructose 6-phosphate by 
the action of phosphoglucose isomerase. Another phosphate 
group is then added by one of the key enzymes of glycolysis 
phosphofructokinase (PFK) and fructose 1,6-biphosphate is 
produced. PFK is a potential candidate for the rate limiting 
enzyme of glycolysis being inhibited by high levels of ATP 
and activated by phosphate ions and AMP. In other words when 
the cell is producing a lot of energy the glycolytic flux is 
slowed down but when it needs energy the glycolytic flux is 
increased. However it has been demonstrated that an increase 
in the level of PFK does not lead to an increase in the 
level of ethanol produced (Heinisch et al 1986). Although 
this may rule out PFK as the main site of regulation of 
glycolysis in yeast, studies have shown concentration 
dependent kinetic behaviour with respect to ATP (Aragon and 
Sanchez, 1985)
Following the production of fructose 1,6-biphosphate there
are several further reactions which end with the conversion 
of phosphoenolpyruvate to pyruvate using the enzyme 
pyruvate kinase (See figure 1.1.1). This step is another 
controlling one which is activated by fructose 1,6- 
biphoshate thus allowing the enzyme to keep up with the pace 
of the glycolytic flux.
The result of glycolysis is that two molecules of pyruvate 
are formed from one molecule of glucose with a net gain of 
two molecules of ATP.
In yeast there are two main routes for the utilization of 
pyruvate. The first route for pyruvate is for it to enter 
the mitochondria and join the TCA cycle (described later) 
and the second is for it to be converted to ethanol. The 
path that is taken depends on the prevailing conditions and 
the yeast species.
Ethanol production from pyruvate depends on the presence of 
two enzymes pyruvate decarboxylase and alcohol 
dehydrogenase. The first step is the removal of carbon 
dioxide from pyruvate to form acetaldehyde. Secondly, the 
acetaldehyde is acted on by alcohol dehydrogenase to form 
ethanol.
Of the two pathways available the one that produces more 
energy is the mitochondrial pathway which gives rise to 36 
mol ATP/mol glucose against 2 mol ATP/mol glucose produced 
during fermentation. So, as would be expected, some yeasts 
will preferentially convert glucose all the way to carbon 
dioxide and water in the presence of oxygen, and if the
Figure 1.1.1
Transport of sugars and the glycolytic path in yeast. 
The transport of the major sugars utilized by 
S.cerevisiae is shown and their possible fates once 
inside the cell. The enzymes catalysing the various 
steps are as follows;
1) Phosphoglucose isomerase (R),
2) Phosphofructokinase,
3 and A) Aldose,
5) Triose phosphate isomerase (R),
6) Glyceraldehyde 3-phosphate Dehydrogenase(R),
7) Phosphoglycerate kinase (R),
8) Phospoglyceromutase (R),
9) Enolase (R),
10) Pyruvate kinase,
11) Pyruvate decarboxylase,
12) Alcohol dehydrogenase (R)
Enzymes that catalyse reversible reactions are marked R
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5yeast had been previously fermenting then the introduction 
of air into the system will cause the yeast to oxidise the 
glucose. This is known as the 'Pasteur effect'. This 
describes the control of the rate of glycolysis by oxygen 
and states that the rate of glycolysis in yeast is 7 times 
faster in the absence of oxygen than in its presence. 
However this is not the case in S.cerevisiae. The main 
catabolic route, in the presence of glucose, is fermentation 
even during aerobic growth. This is known as the "glucose 
effect". The mechanism of the effect is still unclear. It 
does not appear to be the same as the situation in bacteria 
where glucose phosphorylation causes a drop in the level of 
cyclic AMP, which is required for transcription of the genes 
affected (Gottschalk et al 1979). However the effect seems 
to be restricted to glucose and does not occur to the same 
extent in the brewing process as the main constituent is 
maltose.
1.2 Principles of Brewing
The basics of beer brewing have changed little over the last 
few centuries. Barley is allowed to undergo limited 
germination or "malting" during which time the starch 
contained in the kernels is hydrolysed by beta-amylase to 
maltose. Further degradation of starch comes about when the 
malt is dried, cooked and placed in water at 60-70°C. This 
process of "mashing" produces mainly maltose along with 
small oligosaccharides and dextrins. The soluble extract
6obtained from mashing, called wort, is cooled to a 
temperature suitable for yeast fermentation and inoculated 
with brewers yeast. Fermentation is allowed to continue for 
5-7 days during which time the ale type yeast S.cerevisiae 
tends to rise to the surface.
During this type of so called batch fermentation 5% of the 
available sugar may be used for cell growth and maintenance. 
This is a considerable part of the energy available to yeast 
cells which is ultimately lost or used for animal feed.
Over the last century attempts have been made to improve the 
performance of industrial yeasts by a variety of means. The 
more traditional methods employed are hybridisation and non­
specific mutagenesis while modern methods are protoplast 
fusion and genetic transformation.
1.3 Methods of Improving Industrial Yeasts
1.3.1 Hybridisation
During the period 1934-1935 Satava working in Czechoslovakia 
and Winge in Denmark discovered the nature of the sexual 
cycle of Saccharomyces (Phaff et al 1978). Their studies led 
to the idea that an alteration of generations occurs in 
Saccharomyces ie the vegetative cells are diploid where as 
the ascospores are haploid. Winge and his co-workers 
developed a micro-manipulator which could be used to dissect 
apart the four ascii and then showed that these could be 
crossed to form a diploid cell. Further work by Lindegren in 
the USA showed that heterothallism exists in Saccharomyces
7ie ascospores are one of two types referred to as _a and 
alpha. The consequences of this work for brewers was that 
they could now take two haploid yeasts, each with a 
desirable quality, hybridise them and use the resultant 
diploid for brewing.
An example of the use of hybridisation in brewing technology 
was reported by Tubb et al in 1981. The authors introduced 
the ability to utilize dextrins into a brewing strain of 
S.cerevisiae by hybridisation of this strain with another 
that produced the enzyme dextrinase. However their work also 
showed the disadvantage of this type of improvement in that 
the hybridisation also introduced an undesirable change 
which in this case was a phenolic-off flavour.
Hybridisation in brewing yeasts is made difficult by the 
tendency of these strains to be polyploid or even aneuploid. 
As a consequence of this these strains do not have a mating 
type, have a low degree of sporulation and poor spore 
viability. These factors make genetic analysis difficult. 
However this level of ploidy protects brewing strains from 
potentially harmful mutations and thus offers the brewer a 
consistent strain of yeast to work with.
1.3.2 Mutagenesis
Non-specific mutagenesis can be used to produce novel 
strains of yeast albeit in rather a random manner. Mutagens 
employed are either radiation (ultra-violet light or x-rays) 
or chemicals (usually ethylmethane sulphonate,
nitrosoguanidine or diethyl sulphate). An example of the use 
of mutagenesis is the work of Jones and co-workers (1987). 
This group reported the isolation of a glucose derepression 
mutant in a brewing strain of yeast. The mutant was 
insensitive to the non-metabolizable but repressing analogue 
of glucose, 2-deoxyglucose. By avoiding glucose repression 
of other sugar transporters the mutant strain was able to 
utilize a range of sugars in the presence of glucose.
The disadvantage of this type of mutagenesis is its non­
specificity ie more than one mutation may have been induced. 
This can be avoided by directing the mutagenesis, which will 
be discussed later.
1.3.3 Spheroplast Fusion
Spheroplast fusion of yeasts was first demonstrated by Van 
Solingen and Van Der Platt in 1977. Since then many workers 
have used this technique to fuse yeast cells together. It 
has been found that it is not only possible to fuse together 
yeast of the same genus (intergeneric fusion) but it is also 
possible to fuse yeast of different genra (intrageneric 
fusion).
Spheroplast fusion is basically a type of hybridisation 
except in this case there is no need for the yeasts to be of 
opposite mating types or to be haploid. The procedure for 
fusion is to remove the cell wall enzymatically and then 
fuse the spheroplasts together in the presence of 
polyethylene glycol and calcium chloride.
8
9An example of intergeneric fusion is demonstrated by the 
work of Russell and Stewart in 1979. The authors fused 
together a polyploid brewing strain of yeast, that was non- 
flocculant, with a flocculant haploid yeast. The resultant 
fusant was able to ferment maltose and was flocculant. 
Another important consequence of the fusion was that the 
yeast sporulated well unlike its polyploid parent thus 
making genetic analysis possible. Unfortunately the fusion 
yeast produced an unpalatable drink with a heavy phenolic 
off flavour. This demonstrates the limitations of 
spheroplast fusion namely that undesirable characteristics 
can be introduced during fusion.
An example of intrageneric fusion is demonstrated by the 
work of Farahnak et al in 1986. The authors were trying to 
combine the characteristics of two different genra of yeast. 
They wanted the fermentative power of S.cerevisiae combined 
with the ability of Kluveromyces fragils to ferment lactose. 
Although K.fragills is able to ferment lactose only a 
fraction of the available lactose is used. A hybrid produced 
from the two genra may be able to utilize a greater fraction 
of the lactose available than K.fragilis alone. This would 
have important consequences for industry since whey, the 
source of lactose, is at best wasted and can be a serious 
pollutant. The authors found that their fusion yeast 
produced 30% more ethanol than the K.fragills parent during 
growth on lactose. This appeared to be due to an increase in 
ethanol tolerance rather than the rate of ethanol
10
production. Although the fusant appeared stable the long 
term stability was in doubt.
1.3.4 Transformation
Genetic transformation is now probably the most widely used 
method for improving industrial yeasts. S.cerevisiae was 
first shown to be transformable by Hinnen and co-workers 
(1978) who showed that leucine dependent cells could become 
independent of leucine when treated with wild type DNA in 
the presence of calcium chloride. Soon after this discovery, 
Beggs (1978) demonstrated that it was possible to swap 
vectors between E.coli and S.cerevisiae by creating a
chimeric plasmid called a shuttle vector. The vector was
able to exist in both types of cell because it contained 
both bacterial and yeast origins of replication.
With the ability to introduce DNA into yeast came the
opportunity to change the genetic make-up of industrial 
organisms in a way that had never previously been possible. 
There are two basic ways in which the genetic make-up of a 
yeast cell can be changed using a plasmid. Firstly it is 
possible to introduce a plasmid borne gene into a cell which 
will autonomously replicate. This requires the presence of a 
chromosomal autonomously replicating sequence (ARS) or part 
of the native 2um plasmid containing the origin of
replication. Secondly it is possible to integrate DNA into 
the genome of yeast using an integrating plasmid or just 
linear DNA.
11
1.3.4.1 Autonomously Replicating Plasmids
ARS plasmids transform at a high efficiency but are not very 
stable. If the selection pressure that was used to isolate 
them in the first place is withdrawn they are easily lost. 
However stability can be introduced by the use of a plasmid 
containing a gene such as the CEN4 chromosomal centromeric 
gene from chromosome IV of S.cerevisiae. Without the 
centromeric sequences ARS plasmids exist at a high copy 
number per cell however with the sequence they generally 
exist at one or two copies per cell.
A practical application of these genetics techniques is 
demonstrated by the work of Hollenberg and Strasser (1990). 
In both brewing and baking there are polysaccharides that 
S.cerevisiae cannot utilize directly by itself. Instead 
expensive enzymes must be added to produce glucose. To avoid 
this situation the authors isolated two genes from 
Schwanniomyces occidentalis which together completely 
degrade starch to glucose. The genes were attached to 
galactose promoters and transformed into a laboratory strain 
of S.cerevisiae using a centromeric shuttle vector. The 
expression of the genes was found to be inducible by the 
presence of galactose and the extracellular activity of the 
enzymes was comparable with that of wild type Sch 
occidentalis.
1.3.4.2 Integrating Plasmids
Lactose fermentation, as mentioned earlier, is an area in
12
which there is a great deal of commercial interest. The 
protoplast fusion method of combining lactose fermentation 
with ethanol tolerance and a high rate of ethanol production 
could be improved upon by taking just the characteristics 
wanted from a Kluveromyces yeast and adding them to 
S.cerevisiae. This was accomplished by Jeong and co-workers 
(1991). Two types of plasmid were constructed both 
containing lactose utilization genes from K.lactis. The 
first type of plasmid was an integrating one containing no 
yeast origin of replication. This means transformants can 
only occur by integration into the genome. The second type 
was a normal ARS plasmid. The integrating plasmid is far 
more stable that an ARS plasmid but transforms at a much 
lower efficiency. Both plasmids successfully transformed a 
haploid strain of S.cerevisiae into a lactose utilizing 
strain. The integrated plasmid produced a strain able to 
ferment lactose at a faster rate than the strain transformed 
with an ARS plasmid, probably due to the stability of the 
integrated strain.
1.3.4.3 Gene Disruption
Apart from Introducing foreign genes into Saccharomyces 
yeasts, transformation can also be used to delete genes from 
the genome by gene disruption (for a summary of this and 
another integration event see figure 1.3.1). This technique 
was used by Gjermansen et al (1991) to produce a diacetyl­
less lager. Diacetyl is formed from acetolactate by a non-
Figure 1.3.1
Examples of two types of integration into the yeast 
genome. A) In this case an integrating vector cut in the 
gene of interest recombines with an homologous area in 
the yeast genome. The result is the integration of the 
whole plasmid. B) In this case the selectable marker is 
contained within the gene of interest. A fragment 
containing the selectable marker and ideally about 250 
bp of the gene of interest is used to transform yeast 
(Based on Ausebel et al 1987).
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enzymatic oxidative decarboxylation. Acetolactate is formed 
by the action of the enzyme acetohydroxy acid synthase 
encoded by the ILV2 gene. Diacetyl produces an off-flavour 
in lager and normally an expensive and time consuming 
lagering period is required to get rid of it. However if the 
enzyme responsible for production of acetolactate could be 
genetically removed then no diacetyl would be formed. The 
authors used a dominant marker G418 resistance present on an 
integrating plasmid, along with a mutated form of the gene, 
to produce mutations in three of the four wild type genes. 
However deletions of the fourth gene proved impossible as 
this condition was lethal. Subsequent examination showed 
that Saccharomyces calsbergensls has a low uptake rate for 
isoleucine and valine. Acetohydroxy acid synthetase is part 
of the biosynthetic pathway for these amino acids. Therefore 
deleting the gene coding for this enzyme leaves the cell 
short of essential amino acids. However the authors were 
able to isolate ilv auxotrophic strains by sporulation and 
plating on media with large amounts of isoleucine and 
valine.
1.4 Mitochondria
Mitochondria are made up of two membrane components, inner 
and outer, and two aqueous components, the intermembrane 
space and the matrix. These organelles contain the apparatus 
needed to oxidise sugars completely to water and carbon 
dioxide. They also provide building blocks for amino acid
15
synthesis and for gluconeogenesis.
There is strong evidence to suggest that mitochondria were 
derived from free living organisms as they contain their own 
DNA and protein synthesizing apparatus. However the 
mitochondrial genome contains few of its original genes and 
most proteins are now nuclear encoded and are imported into 
the mitochondria. S.cerevisiae mitochondrial DNA (mtDNA) 
codes for 2 rRNAs, 25 tRNAs, 6 known inner membrane proteins 
and 10 more unassigned reading frames or URFs. (Bowman 1989) 
The mitochondria of yeasts perform many tasks and probably 
contribute to others as yet unknown, but the two major 
functions they perform are the generation of ATP via the TCA 
cycle and oxidative phosphorylation and the oxidation of 
fatty acids.
The generation of ATP can be divided into two distinct 
sectors the tri-carboxylic (TCA) cycle or Krebs cycle and 
oxidative phosphorylation
1.4.1 TCA Cycle
The route by which pyruvate enters the mitochondria was 
thought to be via a specific monocarboxylate carrier (Papa 
et al 1971). This was supported by work done using an 
inhibitor that specifically blocked mitochondrial pyruvate 
transport (Halestrap and Denton 1974).
The link between glycolysis and the TCA cycle is the 
oxidative decarboxylation of pyruvate to form acetyl Co-A 
which occurs in the mitochondrial matrix. This is
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irreversibly catalysed by the enzyme complex pyruvate 
dehydrogenase. The fact that this reaction takes place via 
an enzyme complex suggests a complex route, and this is 
indeed the case. There are four steps in the conversion of 
pyruvate to acetyl Co-A.
Once formed the acetyl Co-A condenses with an important 
intermediate of the TCA cycle, oxaloacetate. This is a key 
intermediate because as well as being the 'starting point' 
of the TCA cycle it is also required for gluconeogenesis, 
the formation of glucose which is carried out at times of 
excess energy levels. Oxaloacetate condenses with acetyl Co- 
A to form citrate in a reaction catalysed by the enzyme 
citrate synthetase. There are several further steps 
described in figure 1.4.1 which finally lead to the 
regeneration of oxaloacetate. In the course of the cycle the 
two carbons gained from acetyl Co-A are lost as carbon 
dioxide and five hydrogens are lost as three NADH and one 
FADH2 .
The TCA cycle is constantly being depleted of intermediates 
for biosynthetic purposes and these must be replaced by 
anaplerotic reactions. Two mains anaplerotic pathways exist 
in yeast. The first is catalysed by pyruvate carboxylase 
which at times of high levels of acetyl Co-A produces 
oxaloacetate from pyruvate. The second pathway is the 
glyoxylate cycle which provides succinate and malate from 
acetyl Co-A.
Figure 1.4.1
TCA cycle in mitochondria showing generation of NADH and 
FADH. The Dark band at the edge of the mitochondria 
represents the monocarboxylate (pyruvate) transporter. 
The enzymes and enzyme complexes catalysing the various 
reactions of the cycle are as follows;
1) Pyruvate dehydrogenase complex,
2) Citrate synthase,
3+4) Aconitase (R),
5) Isocitrate dehydogenase (R),
6) Alpha-Ketoglutarate dehydrogenase complex (R),
7) Succinyl CoA synthetase (R),
8) Succinate dehydrogenase (R),
9) Fumarase (R),
10) Malate Dehydrogenase (R).
Enzymes catalysing reversible reactions are marked R
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1.4.2 Oxidative Phosphorylation
The NADH and FADH2 formed during the oxidation of glucose 
are energy rich molecules each containing a pair of 
electrons with a high transfer potential. When these are 
donated to molecular oxygen a large amount of free energy is 
liberated which is used to generate ATP. This is the major 
source of ATP in the yeast cell providing 32 of the 36 
molecules of ATP formed during the oxidation of a molecule 
of glucose.
The outer membrane is freely permeable to most small 
molecules as it is transversed by many porin molecules. 
These are proteins with a large pore that allows the passage 
of most small molecules. However the inner membrane is not 
so permeable and specific carriers such as the
monocarboxylate and dicarboxylate carriers are required. The 
inner membrane also contains the apparatus needed for 
oxidative phosphorylation.
The molecules NADH and FADH2 donate their energy by passing 
electrons down a chain of proteins and protein complexes 
known as the respiratory chain. The respiratory chain 
consists of three enzyme complexes linked by two mobile 
electron carrier (Figure 1.4.2). The pathway is as follows;
1) NADH reduces NADH-Q reductase (complex I)
2) NADH-Q reductase reduces ubiquinone, a mobile hydrophobic 
carrier
3) Reduced ubiquinone reduces cytochrome reductase (Complex 
III)
Figure 1.4.2
Diagramatic repesentation of the respiratory chain 
shoving the the generation of a proton gradient by the 
passage of electrons and subsequent generation of ATP. 
The components of the respiratory chain are represented 
as follows;
Cl) complex 1, NADH-Q reductase,
Q) ubiquinone,
CII) complex 2, succinate-Q reductase,
CIII) complex 3, cytochrome reductase, 
c) cytochrome c_,
CIV) complex 4, cytochrome c_ oxidase.
ATP synthetase is represented as ATP syn.
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4) Cytochrome reductase reduces cytochrome c
5) Cytochrome c reduces cytochrome oxidase (Complex IV).
6) Electrons from FADH2 are passed into the respiratory 
chain via succinate-Q reductase complex (Complex II).
This complex does not act as a proton pump and hence only 
two molecules of ATP are formed per molecule of FADH2.
In yeast NADH external to the mitochondria is utilized with 
the help of an externally located NADH-ubiqulnone 
oxidoreductase, thus eliminating the need for complex 
shuttle systems.
The passage of electrons is coupled to ATP synthesis by an 
intermediate factor. This factor has been the subject of 
long and heated debate, however most workers agree that as a 
base the Chemiosmotic Theory is the most likely explanation 
of events. This theory was proposed by Peter Mitchell in 
1961 (Mitchell 1961). He suggested that electron transport 
and ATP synthesis were coupled by a proton gradient across 
the inner membrane of the mitochondria. Evidence for this 
theory has built up over the years:
1) ATP is synthesised when a pH gradient is imposed on the 
mitochondria in the absence of electron transport.
2) Synthetic vesicles containing bacterlorhodopsin (which 
pumps protons when illuminated) and mitochondrial ATPase was 
able to synthesise ATP( Racker and Stoeckenius 1974).
3) Solubilized mitochondrial preparations do not synthesise 
ATP.
4) Substances that are known to carry protons from high
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concentrations to low, stop the synthesis of ATP, presumably 
by dissipating the membrane potential.
There are discrepancies in the theory such as accounting for 
ATP synthesis in some halophillic bacteria (Helgerson 1983) 
which have a very small membrane potential. Thus there is no 
absolute theory for the coupling of electron transport to 
ATP synthesis and it may be some time yet before the full 
story is known.
1.4.3 Oxidation of Fatty Acids
Kennedy and Lehninger showed in 1949 (Stryer 1988) that 
fatty acids are oxidised in the mitochondria. The fatty
acid is linked to coenzyme A by the enzyme acyl Co A 
synthetase at the expense of ATP. If the acyl chain of the 
fatty acid is long then the inner membrane is not easily 
transversed. In order for these molecules to get across the 
membrane a specific transporter, carnitine, is needed. This 
molecule releases the coenzyme A and allows the passage of 
the newly formed acyl carnitine through the inner membrane 
via a translocase. Once on the matrix side the acyl group is 
transferred to coenzyme A again and the oxidation of the 
acyl chain can begin.
The chain is shortened by two carbon units each time it goes 
round the so-called beta-oxidation chain. This oxidation 
releases FADH2 and NADH which can then transfer their high 
energy electrons to the electron transport chain and thus 
generate ATP.
22
1.4.4 Petites
Some yeasts Including all strains of Saccharomyces are able 
to survive without the presence of viable mitochondria. In 
other words they derive enough energy from fermentation to 
be able to survive on a substrate such as glucose. Such 
yeast are termed petites because their growth on glucose 
agar is distinctive in that they produce smaller colonies 
than the wild type grandes. The non-functioning mitochondria 
can arise from a mutation in the mitochondrial genome (rho°. 
rho~. or mit~) or a deletion in a nuclear gene that is 
targeted to the mitochondria (pet mutant).
Petites occur naturally in a population of yeast at 1-2X but 
can arise from treatment with mutagenizing reagents such as 
ethidium bromide, acriflavine and ethyl methane sulphonate. 
Examination of mtDNA from some spontaneous petite mutants 
(Bernadi et al 1968) revealed a gross alteration in the GC 
content from its former level of 18X to 4X. The reason for 
this change became clear when it was revealed that the 
mechanism by which the mutation had occurred was excision of 
an AT spacer. These areas rich in AT bases multiplied and 
eventually became the petite genome so that there are no, or 
few, coding regions left in the genome.
Prolonged treatment with ethidium bromide can remove all of 
the mtDNA, these are the rho° yeasts mentioned earlier with 
no functional mtDNA. If there is some coding region left the 
yeast is termed a rho~. If there is a mutation in a single 
gene then the yeast is termed mit~.
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The pet mutants ace mutations in nuclear genes which affect, 
directly or indirectly, the functioning of the mitochondria. 
A recent review by Tzagoloff and Dieckman (1991) claimed to 
represent all PET genes present in the yeast genome. Some 
pet mutations are straightforward, in that the genes they 
are mutated in, code for a protein directly involved in 
respiration. For instance the PET9 or 0P1 gene codes for the 
ADP/ATP translocator in yeast (O'Malley et al 1982). A 
mutation in this gene leads to an absence of ADP essential 
for ATP synthesis and hence mutants are unable to grow on a 
non-fermentable media. Other mutations are rather more 
convoluted. Such is the case of the PET122 gene (McKewen et 
al 1988) which codes for a protein necessary for the 
translation of a single mitochondrial mRNA that encodes 
subunit III of the cytochrome c, oxidase complex. Although 
this gene does not code for a protein used in respiratory 
function it does code for a protein necessary for 
translation of a respiratory chain subunit mRNA.
1.5 Genetic Control of the Nucleus Over the Mitochondria 
The vast majority of mitochondrial proteins are nuclear 
encoded. How is it then that these proteins reach their 
destination? Workers in the early eighties discovered that 
amino terminal sequences of nuclear encoded mitochondrial 
proteins determine their ultimate destination. Recently an 
exception has been discovered in the shape of the ATP/ADP 
translocator. This protein possesses targeting sequences
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within the mature protein (Pfanner et al 1987). Most 
mitochondrial import studies over the last decade have been 
carried out on Neurospora crassa and yeast.
Many imported mitochondrial proteins are synthesised with 
amino terminal presequences of 20-80 amino acid residues. 
These presequences carry targeting information to direct 
proteins into mitochondria and are made of mainly positively 
charged basic residues with few acidic residues.
Specific receptors exist on the outer membrane of the 
mitochondria which recognise the target sequence. Two 
receptors have been identified to date. MOM19 (Sollner et al 
1989) is the receptor for proteins with an amino terminal 
presequence and MOM72 (Sollner et al 1990) is the receptor 
for the ATP/ADP translocator. The equivalent proteins in 
yeast are probably M0M17 (Kiebler et al 1990) and MAS70 
(Hase et al 1984).
After being received at the outer membrane, precursor 
proteins are inserted into the membrane. Nearly all proteins 
appear to use the same insertion site. The site was given 
the name "general insertion protein" or GIP (Pfanner et al 
1988). Recent woirk has suggested the protein is MOM38 
(Kiebler et al 1990). It is conceivable that the import site 
protein 42, or ISP42, of yeast (Ohba and Schatz 1987) is the 
analogue of the GIP in N.crassa.
Apocytochrome the precursor of cytochrome is imported 
in a unique way. It is able to insert into membranes without 
the help of any other proteins such as a protease sensitive
25
receptor or a GIP (One of several). The mature protein is 
found in the intermerabrane space.
Proteins are translocated Into the matrix by crossing both 
membranes at a contact point (Schleyer and Neupert 1985) ie 
the point where the outer and inner membranes are extremely 
close.
Presequences are cleaved off by a mitochondrial processing 
peptidase, MPP (Yang et al 1988) which has a low protease 
activity unless accompanied by a second enzyme protease 
enhancing peptidase, PEP (Yang et al 1988). The equivalents 
in yeast are MAS2 and MASl (Pollock et al 1988). Some 
presequences are cleaved in two steps. The first removes the 
matrix targeting sequence and the second removes the 
intermembrane targeting sequence. Most intermembrane 
proteins have this two part presequence (Hartl et al 1989). 
The second presequence differs from its partner in that it 
is relatively hydrophobic.
Once the mature protein is present in the mitochondrial 
matrix it is folded or refolded to their mature 
configuration and are sometimes built into multimeric 
complexes. In yeast this appears to require the presence of 
ATP and a protein called hsp60 (Osterman et al 1989). 
Intermembrane proteins do not become folded by this protein 
but hsp60 may induce a conformation change that allows 
passage across the inner membrane.
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1.6 The Influence of the Mitochondrial Genome on Nuclear 
Genes
As early as the mid seventies it was known that the 
mitochondrial genome exerted some affect on nuclear genes. 
Colson and co-workers (Colson 1974) produced a yeast mutant 
that was resistant to oligomycin and venturicidin. In the 
diploid state the venturicidin resistance was abolished by 
the introduction of mitochondrial oligomycin resistance. 
Another area of mitochondrial control was discovered later 
in the same decade. Yeast cells that were rho~ were found to 
be unable to utilize certain sugars such as maltose 
although they could still utilize glucose (Khan and Greener 
1977). Treatment of cells with the solvent 
dimethylsulphoxide (DMSO) allowed cells to grow suggesting 
that the apparatus for utilization was present but the 
inducible permease was not. Later work revealed the 
involvement of nuclear genes in this system. Khan (1982) 
discovered a nuclear gene which was necessary for maltose 
utilization in rho~ cells, he called this gene PMU1 (petite 
maltose utilization).
How is it that the mitochondrial genome can influence 
nuclear genes? There is no direct evidence of a protein or 
other molecular signal as of yet. However there is evidence 
of a path of communication between the mitochondria and the 
nucleus which might influence gene regulation. Work carried 
out by Butow and co-workers (Parikh et al 1987) showed that 
abundance of some transcripts of the nuclear genome varied
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up to five time according to the condition of the mtDNA. The 
authors work suggests that the nucleus reacts in response to 
the quality and quantity of mtDNA. The greatest abundance of 
transcript was reported to be in a rho~ yeast and the 
smallest amount was shown to be in the parental grande 
yeast. The mechanism by which this control is exerted has 
been suggested to involve export of mitochondrial RNA that 
functions as a regulator (Parikh et al 1987).
1.7 Aims and Approaches
To study the affect petite and petite type mutations would 
have on a brewing performance, it will be necessary to 
introduce specific mutations into S.cerevisiae strains 
capable of fermenting brewers wort. This would be carried 
out by a one step gene disruption (Rothstein 1983). 
Initially this would be carried out in a haploid yeast, if 
this were successful then mutations would be introduced into 
a polyploid brewing yeast.
The two particular mutations studied in this thesis are the 
pet!22. which prevents expression of subunit III of the 
cytochrome c, oxidase complex (Ohmen et al 1988), and tpyl, a 
putative mutation in mitochondrial pyruvate transport (Hills 
et al 1986).
These mutations were chosen because of their different areas 
of action. The pet!22 mutation prevents the passage of 
electrons past cytochrome c_ in the electron transport chain. 
The tpyl mutation prevents entry of pyruvate into the
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mitochondria. However reducing equivalents are able to enter 
the mitochondria, thus not all respiratory function is 
absent.
As well as trying to introduce the tpyl mutation into a 
brewing yeast it would be interesting to try and establish 
its true nature. The paper describing the mutation was by no 
means certain of its origin. An attempt will be made to try 
and clone the TPY1 gene and to study isolated mitochondria. 
To examine the affect a mutation in mitochondrial pyruvate 
transport would have on fermentation performance, a specific 
inhibitor of this function, alpha-cyano-4-hydroxycinnamic 
acid, will be used in brewing trials.
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CHAPTER 2
Disruption of PET122 Gene and Subsequent Brewing Trials
2.1 Introduction
The respiratory chain of yeast mitochondria responsible for 
the passage of electrons from NADH to oxygen is made up of 
three major enzyme complexes which are located in the inner 
mitochondrial membrane.
The final complex,which is responsible for passing electrons 
to molecular oxygen, is cytochrome £  oxidase. The complex is 
made up of nine subunits in S.cerevisiae three of which are 
coded for by the mitochondrial genome.
Genetic disruption of the complex in S.cerevisiae leads to 
formation of petite cells unable to produce a proton 
gradient and hence unable to produce mitochondrial ATP. If 
the level of intracellular ATP is lower than normal then 
phosphofructokinase (PFK) will not be inhibited and, 
consequently, neither will glycolytic flux. As well as this 
the mitochondria will be non-functional and so pyruvate 
would be mostly fermented.
If a nuclear gene encoding a protein necessary for function 
of the cytochrome £  oxidase complex were to be mutated in a 
brewing strain of yeast, then this mutation's effect on 
fermentation performance could be observed. The gene 
selected was cloned by Ohmen and co-workers (1987) and is 
called PET122. The gene is required for the expression of 
the mitochondrial C0X3 gene in S.cerevisiae. In order to 
disrupt the PET122 gene a marker is required. The marker
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used in the disruption described in this chapter is 
resistance to the antibiotic G418. The resistance is 
associated with the APT2 gene. This gene codes for an enzyme 
which provides resistance by catalysing the transfer of a 
phosphate group from cellular ATP to the 2-deoxystreptamine 
moiety at the 3' hydroxyl side group of the antibiotic thus 
rendering it inactive (See figure 2.1.1).
Figure 2.1.1 Inactivation of the Antibiotic G418 
by Cellular ATP
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2.2 Materials and Methods
Bacteriological peptone, yeast extract, bacto-agar, and 
bacto-tryptone were purchased from Difco labs, Detroit 
Michigan, USA. Ampicillin sulphate, kanamycin sulphate, and 
G418 sulphate were purchased from Sigma chemicals, Poole, 
Dorset, UK. Polyethylene glycol was purchased from Fisons, 
Loughbourough, UK. All other reagents were of 'AnalaR' 
grade. All restriction enzymes and buffers were supplied by 
Glbco-BRL.
2.2.1 Maintenance of Escherichia coli Strains
Escherichia coli Strains.
TGI (Sambrock et. al. 1989)
TG2 (Sambrock et. al_ 1989)
Il.l.b. Short-Term Storage:
Stock strains of Escherichia coli were maintained by plating 
out individual colonies onto glucose/minimal medium plates 
followed by incubation at 37°C overnight and storage at 4°C. 
This process was repeated monthly.
Glucose/Minimal Medium. 10xM9 Salts.
15g Minimal Agar in 900ml SDW 6% (w/v) Na2HP04
100ml 10XM9 Salts 3* (w/v) KH2P04
lml 1M MgS04 IX (w/v) NH4C1
lml 0.1M CaCl2 0.5% (w/v) NaCl
lml 1M Thiamine HCl
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10ml 20X (w/v) Glucose
All components of glucose/minimal medium plates were made up 
with SDW, autoclaved separately and cooled before mixing 
aseptically.
Long-Term Storage:
A single bacterial colony was grown overnight at 37°C in 
10ml L-broth in an orbital shaker ar 200rpm. 850ul of
overnight culture were transferred to a vial containing 
150ul of sterile glycerol and mixed. Glycerinated cultures 
were stored at -80°C.
L-Broth.
IX (w/v) NaCl
IX (w/v) Bacto-Tryptone
0.5X (w/v) Yeast Extract
(To make L-agar, 2X agar was added to the above components 
before autoclaving).
2.2.2 Preparation of Competent Cells. (Cohen et al 1972) 
Escherichia coli cells of the appropriate strain were picked 
from a single colony and used to inoculate 10ml of L-broth 
which was grown overnight, to stationary phase, at 37°C in 
an orbital shaker at 200rpm. 40ml of L-broth were inoculated 
with 2ml of this overnight culture and grown at 37°C in an 
orbital shaker at 200rpm for 1^-2 hours, to mid-log phase 
(until the ODjjq was approximately 0.3). Cells were pelleted 
by centrifugation at 2000xg for 5 minutes at 4°C, then 
resuspended in 20ml sterile lOOmM CaCl2 which had been pre­
33
chilled on ice. The resuspended cells were left on ice for 
20 minutes before repeating the centrifugation step and 
resuspending in 4ml cold lOOmM CaC^. Cells were left on ice 
for at least an hour before use, or stored at 4°C and used 
within 48 hours. The efficiency of transformation obtained, 
using cells prepared in this way, increases with time of 
storage then declines after 24 hours.
2.2.3 Transformation of Escherichia coli with Plasmid DNA. 
(Cohen et al 1972)
Approximately lng of the DNA was gently mixed with lOO/il 
competent cells in pre-chilled Eppendorfs and incubated on 
ice for 45 minutes with intermittent gentle mixing. Cells 
were heat-shocked by incubation at 42°C for 2 minutes then 
diluted with 1ml L-broth and incubated at 37°C for 40 
minutes. The transformed cells were then pelleted in an 
Eppendorf centrifuge by spinning for 1 minute at low speed, 
and then resuspended in lOOul L-broth prior to spreading on 
L-agar plates (see L-broth), containing ampicillin if 
required.
When insertional inactivation of the lacZ gene in the 
plasmid was to be used for selection of recombinant DNA 
molecules, iosopropyl-l-thio-B-D-galactoside (IPTG) and 5- 
bromo-4-chloro-3-indolyl-B-D-galactoside (X-GAL) were added 
to the plates.
Ampicillin and Kanamycin.
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Ampicillin was prepared as a 50mg/ml stock solution in SDW 
and stored at -20°C. This stock solution was added to liquid 
media or cooled agar-containing media just before pouring, 
to give a final concentration of 50pg/ml. Kanamycin was 
prepared as a 30mg/ml stock solution in SDW and stored at 
-20°C. This stock solution was added to liquid media or 
cooled agar-containing media to give a final concentration 
of 30/ig/ml.
IPTG. X-GAL.
lOOmM stock (23.8mg/ml in SDW) lOOmM stock (20mg/ml in
dimethylformamide)
(Both stock solutions were prepared just before use and 
added to cooled L-agar just before the plates were poured). 
The following control transformations were always carried 
out:
-A transformation with no added DNA to check for 
contamination.
-A transformation containing lng ds DNA to monitor cell 
competence, (expect 10^ colonies per ng). If IPTG and XGAL 
were used, the control DNA used also conferred beta- 
galactosidase activity on the cell so that the effectiveness 
of the blue/white selection could also be monitored .
2.2.4. Small Scale Isolation of Plasmid DNA from E.coli. 
(Based on Holmes and Quigley 1981)
10ml aliquots of L-broth containing ampicillin at 50/ug/ml 
were inoculated with E.coli cells from individual colonies
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selected from L-agar plates containing 5Qug/ml ampicillin. 
Cells were grown overnight at 37°C in an orbital shaker at 
200rpm and then harvested by centrifugation at 2000g for 10 
minutes at room temperature. Each pellet was resuspended in 
lOOjil of 25X (v/v) sucrose/50mM Tris-Cl pH8.0. (filter- 
sterilised) and transferred to an Eppendorf. 600/j1 of MSTET 
and lpl of freshly prepared lysozyme 50mg/ml in Tris-Cl 
pH8.0 were added to each sample just before boiling for 60 
seconds. The lysed cells were placed on ice to cool and then 
pelleted by centrifugation for 1 hour at room temperature in 
an Eppendorf centrifuge. The supernatant from each sample 
was removed and incubated at 37°C for 30 minutes after the 
addition of 2pl ribonucleaseA. Each sample was 
phenol/chloroform extracted. DNA was precipitated by the 
addition of 1/10 volume 3M sodium acetate pH6.0 
(autoclaved),and an equal volume of isopropanol followed by 
freezing on dry-ice for 30 minutes. Samples were pelleted by 
centrifugation as above for 15 minutes and dried under 
vacuum before resuspending in lOO/il SDW. The samples were 
ethanol precipitated then resuspended in lOOjul SDW or TE.
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MSTET.
5% (w/v) Sucrose 
50mM Tris-HCl pH8.0 
50mM EDTA
5% (v/v) Triton X-100 
(All components were 
autoclaved. The sucrose 
solution was filter- 
sterilised.
TE.
lOmM Tris-Cl pH8.0 
lOmM EDTA pH8.0 
(autoclaved) 
RibonucleaseA.
Made up in SDW to lOmg/ml 
then boiled for 10 
minutes and cooled before 
use.
2.2.5 Preparation and use of Phenol.
lOOg of chromatography grade phenol was dissolved in 100ml 
of 1.5M Tris-Cl pH8.0 and 0.1% (w/v) 8-Hydroxyquinoline was 
added to aid identification of the organic phase and to act 
as an antioxidant. The top (aqueous) phase was replaced with 
fresh 1.5M Tris-Cl pH8.0 and mixed with the organic phase; 
this process was repeated until the aqueous phase was 
between pH7.5 and pH8.0. The aqueous layer was then replaced 
with lOmM Tris-Cl pH8.0. After mixing, the phenol was stored 
in aliquots at -20°C. When required, an aliquot was thawed, 
used at room temperature and stored for the short-term at 
4°C. (Tris-Cl solutions had been autoclaved). 
Phenol/Chloroform Extaction of DNA.
All the following manipulations were carried out at room 
temperature, unless otherwise stated. The sample was mixed 
with an equal volume of phenol in an Eppendorf tube until an 
emulsion formed, then spun at high speed in an Eppendorf
37
centrifuge for 3 minutes. The upper, aqueous phase was 
transferred to a clean Eppendorf, care being taken to avoid 
the interface, and an equal volume of a 1:1 mixture of 
phenol and chloroform added. The sample was mixed, spun, and 
then the upper, aqueous phase transferred, as above. This 
step was repeated if there was a large amount of protein at 
the interface. An equal volume of chloroform was added to 
the aqueous phase and the sample which was then mixed, spun 
and transferred as above. The DNA was recovered by ethanol 
precipitation of the aqueous phase.
Ethanol Precipitation of DNA.
2 volumes of ice-cold ethanol and 1/10 volume 3M sodium 
acetate pH 6.0 (autoclaved) were added to the sample which 
was then placed on dry-ice for 20 minutes or at -20°C for 
several hours. The sample was then spun at high speed in an 
Eppendorf centrifuge at 4°C for 15 minutes and the 
supernatant carefully removed. The pellet was then washed 
with 200/il 80% (v/v) ethanol, which had been pre-chilled to 
-20°C. The supernatant was removed and the pellet dried 
under vacuum before resuspension in SDW or TE.
2.2.6 Large Scale Plasmid DNA Isolation from E.coli.
(Based on Promega Biotec Technical Bulletin N°9).
Cells containing plasmid were grown overnight in 10ml of L- 
broth and 5Qfug/ml ampiclllin at 37°C in an orbital shaker at 
200rpm. 250ml of L-broth containing 50pg/ml ampicillin was 
then inoculated with 2.5ml of this overnight culture and
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grown overnight at 37°C as above. Cells were pelleted by 
centrifugation at 2000g for 10 minutes at 4°C, then 
resuspended in 4ml of lysis buffer and placed on ice for 15 
minutes. 8ml of alkali detergent solution were then added 
and the suspension which was gently mixed until transparent. 
After 10 minutes on ice, 5ml of 3M sodium acetate pH4.6 
(autoclaved) was added and the suspension mixed until it was 
converted into a dense white precipitate. After 15 minutes 
on ice, this precipitate was pelleted by centrifugation at 
17000g for 15 minutes at 4°C. The clear supernatant was 
transferred to a sterile universal and 5jul of a lOmg/ml 
solution of ribonucleaseA added to it before incubation at 
37°C for 30 minutes. 0.5 volumes of phenol/chloroform were 
then mixed with the supernatant which was then left at room 
temperature for 15 minutes. The mixture was centrifuged at 
3000g for 10 minutes at room temperature, the upper phase 
transferred to a clean universal and the phenol/chloroform 
treatment repeated until the top phase was transparent. DNA 
was precipitated from the top phase by the addition of 0.6 
volumes of isopropanol and incubated for 15 minutes on ice. 
The sample was then spun at 17000g for 10 minutes at 4°C and 
the resulting pellet resuspended in 1.6ml of SDW, to which 
0.4ml of 4M NaCl and 2ml of 13X polyethylene glycol 
(autoclaved) were then added. The sample was left on ice for 
an hour and then spun at room temperature for 10 minutes at 
high speed in an Eppendorf centrifuge. The supernatant was 
removed with a drawn-out Pasteur pipette and the pellet
washed twice with 80X (v/v) ethanol, dried under vacuum and 
resuspended in 50>il of SDW or TE. DNA concentration was 
estimated by running an aliquot of the sample along-side 
samples of known concentration on a agarose gel. This gel 
was then visualised under U.V. light and the DNA 
concentration estimated by eye.
Lysis Buffer. Alkali Detergent Solution.
25 mM Tris-Cl pH 8.0 0.2 M NaOH
10 mM EDTA IX SDS
15X Sucrose
2mg/ml Lysozyme
(Tris-Cl, EDTA, sucrose and SDS solutions were autolaved).
2.2.7 Digestion of DNA with Restriction Endonucleases.
The following were pipetted into a clean Eppendorf tube:
Xul DNA (0.lug to Aug in SDW or TE)
2pl lOx Restriction Buffer
(18-X);al SDW (so that the total volume was 20;ul)
Restriction endonuclease was added at 1 to 5 units per jig 
DNA and the reaction incubated at the temperature 
recommended by the enzyme manufacturers (usually 37°C but 
30°C for Smal) for 1 to A hours.
The volume of restriction enzyme(s) added was less than 1/10 
the reaction volume. Appropriate restriction buffers were 
supplied with the enzyme by the manufacturers.
In principle, 1 unit of restriction endonuclease completely 
digests lpg of purified DNA in 60 minutes, using the
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recommended assay conditions. However, crude DNA 
preparations, such as the small-scale preparations outlined 
in section 2.2.4, often required more enzyme and/or more 
time for complete digestion.
If digestion by two restriction endonucleases was required, 
a restriction buffer was chosen in which both enzymes are 
relatively active. If the buffers of the enzymes were too 
dissimilar, the DNA was first digested by the enzyme active 
at the lower salt concentration, then sufficient 1M NaCl (1 
to 3jj1 for a 20^1 reaction) was added so that the final 
concentration was appropriate for digestion by the second 
enzyme which was then added to the incubation mixture.
2.2.8 Preparation and Running of Agarose Gels.
A IX (w/v) agarose gel was prepared by adding 0.5g agarose 
to 5ml lOxTBE and 45ml SDH and heating in a microwave oven 
with intermittent mixing until the agarose was completely 
dissolved. The solution was allowed to cool to approximately 
50°C and then ethidium bromide added (from a stock solution 
of lOmg/ml in SDH) to give a final concentration of 
0.5/ig/ml. Gels were cast in a BRL "Horizon 58" horizontal 
slab gel apparatus with the required well-former inserted. 
When the gel was completely set, the well-former and end- 
sealers were removed and the gel immersed in lxTBE 
containing ethidium bromide at 0.5/ug/ml, to cover the gel to 
a depth of 1mm. DNA samples and appropriate DNA molecular 
weight markers, were mixed with at least 1/6 volume of 6x
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DNA sample buffer, loaded into the wells and the gel run at 
a constant voltage of 1-6 V/cm. Since DNA is negatively 
charged, it migrates towards the anode. DNA in the gel was 
visualised with an ultra-violet transilluminator, since
ethidium bromide bound to 
fluorescent yield compared to 
lOxTBE.
0.89M Tris Base 
0.89M Boric Acid 
0.02M EDTA (pH8.0) 
(autoclaved)
DNA displays an increased 
that free in solution.
6x DNA Sample Buffer.
30% (v/v) Glycerol
0.25% (w/v) Bromophenol Blue
0.25% (w/v) Xylene Cyanol
2.2.9 Isolation of DNA from Agarose Gels.
(Based on Grivitz et al 1980)
The required DNA band was visualised using a U.V. 
transilluminator. A slot was cut just in front of the band 
(on the anode side) and a strip of Whatman number 1 paper 
which had been pre-soaked in sterile lxTBE placed in the 
slot. A strip of dialysis tubing which had been prepared by 
boiling in ImM EDTA and rinsed thoroughly in SDW, was placed 
in the slot in front of the paper. The gel was returned to 
the tank but lxTBE added to the tank so that it was level 
with the top of the gel on each side but not immersing it. 
The gel was run at 50V for 5-10 minutes then the current 
reversed for 10 seconds. The gel was then viewed using a 
U.V. transilluminator. If the band had not run into the 
paper, the gel was run for a further period. The paper and
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dialysis tubing were transferred to a 1.5ml Eppendorf with a 
hole in the bottom made with a pin. The 1.5ml Eppendorf was 
placed inside a 2ml Eppendorf. DNA was removed from the 
paper by adding lOOul TE to the sample and spinning the 
Eppendorfs at high speed in an Eppendorf centrifuge for 1 
minute. This step was repeated twice then the upper 
Eppendorf containing the paper discarded. The sample was 
spun at high speed for 2 minutes, the liquid transferred to 
a clean Eppendorf, phenol/chloroform extracted and ethanol 
precipitated.
2.2.10 Dephosphorylation of Plasmid DNA.
(Sambrook et al 1989)
When a ligation was carried out using a plasmid which had 
been cut yielding compatible ends, calf intestinal 
phosphatase (CIP) was used to remove 5' phosphate groups 
from DNA to prevent recircularisation of the plasmid without 
insertion of the required fragment during the ligation 
reaction.
Plasmid DNA (approximately ljig) was digested to completion 
with the appropriate enzyme(s), phenol/chloroform extracted 
and ethanol precipitated. The DNA was dissolved in a minimum 
volume of lOmM Tris-Cl pH8.0, then 5/il lOxCIP buffer and SDW 
added to give a final volume of 48pl.
DNA with 5' overhangs was dephosphorylated by the addition 
of 0.1 units of CIP and incubation at 37°C for 30 minutes 
followed by addition of another 0.1 units and the incubation
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continued for a further 30 minutes.
DNA with 5' recessed termini or blunt ends was
dephosphorylated by the addition of 0.1 units of CIP and
incubation at 37°C for 15 minutes followed by incubation at 
56°C for 15 minutes. After addition of another 0.1 units of 
CIP, incubation at both temperatures was repeated.
40^1 of SDW, lQjul of lOx STE and 5jil of 10% (w/v) SDS were 
added to the sample before heating to 68°C for 15 minutes. 
The sample was then phenol/chloroform extracted, ethanol 
precipitated and resuspended in 10jil of SDW.
IOxCIP Buffer. lOxSTE.
0.5M Tris-Cl pH9.0 lOOmM Tris-Cl pH8.0
lOmM MgCl2 1M NaCl
ImM ZnCl2 10mM EDTA
lOmM spermidine (filter-sterilised)
2.2.11 Blunt-Ending of 5' or 3* Overhangs.
(Sambrook et al 1989)
2jig of DNA was digested to completion with the appropriate 
restriction enzyme(s) in a 20jil reaction volume, ljil of a 
solution containing dATP, dCTP, dGTP and dTTP each at 2mM in 
SDW was then added.
To blunt-end 5' overhangs, the recessed 3' termini were 
filled using the Klenow fragment of E.coli DNA polymerase 
1. 1 unit of Klenow fragment was added for each microgram of 
DNA in the reaction and the sample incubated at room 
temperature for 15 minutes.
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To blunt-end 3' overhangs, the protruding 3' termini were 
removed by utilising the 3' to 5' exonuclease activity of 
bacteriophage T4 DNA polymerase. 2 units of this enzyme were 
added for each microgram of DNA in the reaction and the 
sample incubated at 12°C for 15 minutes.
After the blunt-ending reaction, enzymes in the sample were 
inactivated by heating to 75°C for 10 minutes.
2.2.12 Ligation of DNA Blunt or Cohesive Ends.
(Ausubel et al 1987).
The enzyme T4 DNA ligase was used for both blunt-end 
ligations and ligation of cohesive ends. Between 30ng and 
lOOng of cut plasmid and fragment were used in a ligation 
reaction. Cut plasmid and fragment were generally used at 
ratios of 1:1 and 1:2 (plasmid: fragment) in terms of 
approximate numbers of molecules. The required amounts of 
cut plasmid and fragment were made up to a volume of 9pl 
using SDW, then lOul 2x Ligase buffer, and lunit of T4 
ligase for cohesive-end ligations and 100 units T4 ligase 
for blunt-end ligations were added. Blunt-end ligations were 
incubated at room temperature for 3 hours while cohesive-end 
ligations were incubated at 15°C overnight. Incubation at 
the lower temperature favours the annealing of cohesive ends 
but diminishes enzyme activity. Blunt-end ligations require 
10 to 100 times more enzyme to achieve the same efficiency 
as cohesive-end ligations since the ends are not brought 
together by annealing.
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After ligation, E.coli TG2 were transformed with ljil and 
lOpl aliquots of the sample .
2x Ligase Buffer. 
lOOmM Tris-Cl pH 7.5 
20mM MgCl2 
20mM DTT 
0.5mM ATP
2.2.13 Growth Media for Yeasts
Two types of media were routinely used for growing yeasts.
YPD was used when cells were respiratory deficient or when
the presence of these type of cells did not create a
problem. YPG was used only when cells were respiratory
competent.
When liquid media was required the agar was omitted.
Addition of Antibiotics
G418 sulphate was added directly to hand hot media as a 
solid to obtain a final concentration of 0.5 mg/ml 
Yeast Strains Employed 
C2 - Mat alpha, Mai* ,leu 2, lys 2
X2180-1A - Mat a, mal, gal, SUC^2, CUP 4 (Both Supplied by 
Whitbread PLC)
YPD YPG
1% (w/v) Yeast Extract 
2X (w/v) Bacto-Peptone 
3% (w/v) Glycerol 
2X (w/v) Agar
IX (w/v) Yeast Extract 
2X (w/v) Bacto-Peptone 
2X (w/v) Glucose 
2X (w/v) Agar
46
Preservation of strains
Yeast strains were streaked onto YPD plates every two months 
and placed on YPD slopes in Bijou bottles every six months.
2.2.14 PET122 Gene and G418 Cassette
The PET122 gene was obtained from Joan McEwen (Department of 
Microbiology and the Molecular Biology Institute, University 
of California). The gene was contained in the yeast shuttle 
vector Ycp50 and was named pJD08 (Figure 2.3.1).
The G418 cassette containing the APT2 gene was obtained from 
Chris Hadfield (Biocentre, University of Leicester). The 
cassette was contained in the vector pUC7 and was named 
pCH217 (Figure 2.2.1).
2.2.15 Transformation of Yeast (Ito et al 1983)
Cells were grown overnight to stationary phase in 10ml of 
YPD. The volume of overnight culture used to inoculate a 
fresh one depended on the strain of yeast used but generally 
50ml of fresh YPD was inoculated with 5pl of overnight 
culture and was grown until there were 1-2 x 107 cells 
present (approximately 15 hours).
Cells were washed once in TE and once in LA before being 
resuspended in 0.5ml of LA. The cells were made competent by 
shaking for an hour at 30°C then 0.1ml was added to l-10^ig 
of DNA. The cells and DNA were incubated at 30°C for 10 
minutes after which 0.7ml of PEG solution was added. This 
suspension was incubated for a further 30 minutes at the
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Plasmid Map of pCH217
Sm l
E I-EcoR  I 
Xhl=Xho I 
Sa l=Sa l I
CI=Cla I EV=EcoR  V Xb l=Xba I Bgl=Bgl I 
S sl= Sst  I S m l= Sm a  I HIII=Hlnd III P I=Pst I 
Ba l=Bam H  I
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same temperature and was then heat shocked at 42°C for 5 
minutes. The cells were washed with YPD and plated out onto 
selective media. If expression of antibiotic resistancewas 
required the cells were allowed to recover for one hour in 
YPD prior to plating.
TE
10 mM Tris-HCl pH 8.0 
1 mM EDTA pH 8.0
PEG Solution 
40X Polyethylene Glycol 4000 
Dissolved in LA
2.2.16 DMSO Enhanced Transformation of Yeast (Hill et al 
1991)
Cells were grown in the same way as in the lithium acetate 
transformation procedure. Cells were harvested by 
transferring cultures into two sterile 30ml universal 
plastic tubes (Sterilin) and centrifuged at 4000rpm in a 
bench centrifuge for 5 minutes. The pellets were washed in 5 
ml of lithium acetate solution and pooled into one tube. The 
suspension was centrifuged as above and then resuspended in 
0.5ml of LA solution. 100pl of the yeast suspension is added 
to lOjil of a DNA solution contained in an 1.5ml Eppendorf 
tube. The contents were mixed and then left at room 
temperature for 5 minutes. 280^il of PEG4000 solution (50X
LA
0.1 M Lithium Acetate 
Dissolved in TE
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PEG4000 in LA solution) were added, the contents were mixed 
4-6 times, then the tube was placed at 30°C for 45 minutes. 
DMSO was added to the tube to give a final volume of 10%, 
the contents mixed and then heat shocked at 42°C for 5 
minutes. If antibiotic resistance was to be selected for the 
cells were allowed to 'recover1 by resuspending in 1ml of 
YPD, otherwise cells were plated directly onto selective 
media.
2.2.17 Crossing of Haploid Strains of Yeast
Yeast strains that were to be crossed were grown up for a 
few hours in YPD. A drop of one strain was then placed on 
media that was selective for the cross. A drop from the 
second strain was then placed on top of the first. When the 
plate was dry it was incubated for two days at 30°C.
2.2.18 Formation of rho° Yeast by Ethidium Bromide Treatment 
(Slominski et al 1968)
A stationary yeast culture was used to inoculate 10 ml of 
YPD containing 25pg/ml ethidium bromide. This was shaken 
overnight at 30°C overnight. This culture was then used to 
inoculate another 10 ml of YPD containing 25pg/ml ethidium 
bromide. After a further 24 hours cells were spread on solid 
YPD. After 48 hours small colonies were transferred to YPD 
and YPG solid media. Colonies able to grow on YPD but not on 
YPG were assumed to be rho°.
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2.3 Results
2.3.1 Disruption of PET122 Gene in Plasmid pJD08
The plasmid pJD08 was disrupted with the G418 resistance 
gene as shown in figure 2.3.1. The plasmid was cut at the 
PvuII site contained in the gene generating blunt ends. This 
was treated with CIP to prevent self ligation. The G418 
cassette was cut out of the plasmid pCH217 using EcoRl and 
blunt ended with Klenow fragment in the presence of the four 
dNTP's. The fragment was gel isolated and ligated into the 
PvuII site of pJD08 using T4 DNA ligase.
Transformation of E.coli was carried out by the calcium 
chloride method and cells containing a plasmid were selected 
by their ability to grow on LB plates with 50pg/ml 
ampicillin. Colonies from these plates were placed on LB 
plates containing 30pg/ml kanamycin. Colonies growing on 
this media were presumed to be carrying the G418 resistance 
gene which produces resistance to kanamycin in bacteria. 
Large scale plasmid preparations were carried out on a 
colony that showed both ampicillin and kanamycin resistance. 
Restriction digests of these preparation and those of 
plasmid pJD08 are shown in figure 2.3.2, the new plasmid was 
named pADl.
2.3.2 Disruption of Genomic PET122 Gene of a Haploid Maltose 
Positive Strain of Yeast
The plasmid ADI was digested with the restriction enzymes
Ligation of the G418 Resistance Cassette Into the PET 122 Gene
H p .I 4090 Avr11  3987
XI=Xhs I H IINHInd III Cl=£lfl I PII=Pvu II Dl.Drol
Figure 2.3.1Ligation of the G418 resistance cassette into the PET122 
gene. The cassette was ligated into the unique PvuII 
site in the PET122 gene. .The plasmid pJD08 was 
constructed by ligation of the PET122 into the Hindi II 
and Sail sites of the plasmid Ycp50 (Ohmen et al 1988). 
The shaded area represents the PET122 coding region The 
plasmid construct shown here was named pADl (plasmid map 
taken from Rose et al 1987).
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L 1 2 L
U t*d
L-i
-1636
-1081
-512
Figure 2.3.2
Restriction digests of the plasmids pJD08 (1) 
(2) using HindiII. Lanes marked L contain 
ladder.
and pADl 
the lkb
53
Mlul and Dral producing a fragment of aproximately 2.7 Kb, 
containing the G418 resistance cassette and flanked by 
regions of the disrupted PET122 gene. The fragment was 
isolated from an agarose gel and 20;ig were used to transform 
the maltose utilizing strain C2. Transformants were selected 
by their ability to grow on YPD agar plates containing 
0.5mg/ml G418 sulphate. Transformants were transferred to 
YPG agar plates to test for respiratory competence. All 
fifteen transformants were of a petite nature ie they were 
not able to grow on YPG plates.
2.3.3 Crossing of Mutant Yeast with a rho° Yeast
In order to establish whether the petite formed by 
transformation was of nuclear origin (pet mutant) or of 
cytoplasmic origin (rho°. rho~. or mit~) it was necessary to 
cross the petite with a rho° strain of yeast. To this end 
the petite was crossed with X2180-1A rho° on agar plates 
that selected for growth of the cross ie minimal maltose. 
The diploid was streaked onto YPG agar plates and it grew.
2.3.4 Transformation of Petite with PET122 Gene
To establish if the respiratory incompetence of the petite 
was due to disruption of the genomic copy of the PET122 gene 
the petite was transformed with the plasmid containing the 
original PET122 gene, pJD08. The transformants produced were 
respiratory competent ie they were able to grow on YPG.
2.3.5 Brewing Trial with Mutated Yeast See Appendix 2.
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2 . 4 Discussion
From the results presented in chapter 2 it can be seen that 
the maltose positive yeast strain C2 has been converted to a 
pet!22 mutant.
The restriction digest pattern, of plasmid DNA isolated from 
G418 resistant colonies, is consistent with insertion of the 
2kb G418 resistance cassette in the unique PvuII site of the 
PET122 gene.
A cross between the C2 pet!22 strain and a rho° produces a 
diploid with a phenotype that is a combination of its 
parental strains. Only if the C2 pet!22 has no deletions in 
its mitochondrial genome, can the diploid grow on non- 
fermentable media.
The final proof of the disruption is the phenotypic rescue 
using the pJD08 plasmid, containing the PET122 gene. When 
the yeast C2 pet!22 was transformed with this plasmid it 
restored respiratory competence. The only gene on the 
plasmid that is related to respiratory function is the 
PET122 gene. Therefore it may be concluded that the PET122 
gene has been disrupted in the yeast strain C2.
For a discussion of the brewing trials see Appendix 2.
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CHAPTER 3
Studies of the tpyl Mutant and an Inhibitor of Mitochondria 
Pyruvate Transport
3.1 Introduction
It has been known for some time that petite type yeast cells 
have some advantage over their wild type counterparts in 
terms of fermentative performance (Bacilli and Horri 79, 
Lancashire Personal Communication). In order to try and 
exploit this a putative mutant in mitochondrial pyruvate 
transport was chosen. The mutant was created by Christopher 
Wills at the University of California by ethyl methane 
sulphonate mutagenesis and named tpyl for transport of 
pyruvate.
The mutant produced by Wills had the right characteristics 
for a mitochondrial pyruvate transport mutant. It was unable 
to grow on pyruvate or glycerol but was able to grow on 
ethanol. Some mitochondrial functions remained intact as was 
demonstrated by its ability to grow on glucose in the 
presence of antimycin A even when the mutant lacked ADH 
activity. Antimycin A blocks electron transport at the level 
of cytochrome b, so if the yeast can grow under these 
conditions then reducing equivalents must be getting into 
the mitochondria. Studies of levels of pyruvate 
dehydrogenase and NADH dehydrogenase revealed these enzymes 
to be at levels comparable with that of the wild type yeast. 
Absence of one of these two enzymes could have explained the
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missing link between pyruvate and the mitochondria. 
Therefore some other factor must be responsible for this 
phenotype.
From a brewing point of view it would seem logical that if 
there is a blockage in the pathway to the mitochondria then 
there will be more pyruvate available for fermentation. 
However not all mitochondrial functions would be absent 
since reducing equivalents could still be passed to the 
mitochondria.
The brewing trials performed were designed to simulate the 
affect such a mutation would have in a brewing yeast. The 
inhibitor, alpha-cyano-4-hydroxycinammic acid, acts by 
binding to an essential thiol group of the pyruvate 
transporter and thus inactivates it (Halestrap 1978). A 
different brewing trial involved the use of the mutant tpyl 
and its wild type counterpart.
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Materials and Methods
DSMP+ was purchased from Gallard-Schlessinger Inc. and CCCP 
from Sigma. Both were made up in ethanol.
3.2.1 Media and Yeast strains
Growth media used was as described previously, with the 
addition that the non-fermentable media YPE was used in 
tests for growth of the tpyl mutant.
YPE
2X Ethanol 
2% Bacto-peptone 
IX Yeast Extract
Made up with distilled water. Where solid media was required 
2X Bacto-Agar was added.
Strains
XW153-3C, MAT a, tpyl. SUC2. mal. ga!2, CPPl, adel, trpl, 
ura3
(Supplied by C. Wills University of California)
X2180-1A, MAT a, SUC2, mal, ga!2, CUP1,
Y9, a polyploid ale type brewing yeast.
(Both supplied by Whitbread PLC)
3.2.2 Brewing Trials (Based on Lancashire and Wilde 1987) 
Brewing trials to simulate industrial fermentation 
conditions were carried out in 1000ml tall tubes. Wort was 
diluted until the gravity was approximately 1040. Each tube
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was filled with 500ml of aerated wort, 1ml of ImM zinc 
sulphate, and 2.4 ml of yeast cell suspension containing 
0.5g of cells per ml. When brewing trials were carried out 
with the mutant tpyl an artificial wort was used containing 
4X glucose, 2X bacto-peptone and IX yeast extract. This was 
necessary because the wild type and mutant are unable to 
utilize maltose the main constituent of industrial wort. The 
tubes were maintained at between 18 and 22°C throughout the 
trial. After 24 hours the beer was roused to resuspend the 
yeast. Gravity and ethanol content were estimated after 24, 
48 and 72 hours. After 72 hours only the biomass formed was 
measured.
3.2.3 Gravity Estimation (Lancashire Personal Communication) 
Wort or beer was collected in a universal tube (Sterilin) 
and pumped up and down with a syringe to remove any bubbles. 
The sample was then injected into a density meter (Paar 
Scientific Ltd., Density Meter DMA 35, supplied by Whitbread 
PLC) and the reading was noted.
3.2.4 Alcohol Assay (Based on Bonnichsen 1965)
Beer samples were diluted 10^ times using serial dilutions, 
lOOpl into lOOOpl total volume each time. From the final 
dilution lOO^il were added to 2.9ml of ADH buffer in a 
cuvette. Next 10;il of 50mM NAD'*' was added and then the 
cuvette (sample) was compared with another containing just 
buffer and sample (reference) in an SP1800
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spectrophotometer. The reading taken here at 3 4 0 ^  was 
called Al. When A1 was established 5ul of ADH were added to 
the sample cuvette. After one hour the reading of the sample 
against reference was noted (A2). The final reading (A2-A1) 
was compared against a standard curve of ethanol 
concentrations between 0.5X and 5% by volume.
ADH Buffer
20g Sodium Pyrophosphate 
5g Semicarbazide Hydrochloride 
lg Glycine
Made up in 500ml of distilled water and prior to making up 
to the final volume of 600ml the pH was adjusted to 9 with 
sodium hydroxide.
3.2.5 Preparation of Coupled Mitochondria (Based on Wills et 
al 1986)
Cells were grown to stationary phase in 500ml of YPD with 
good aeration, then spun down in a Sorvall GSA rotor at 
4000rpm for 10 minutes. The pellet was washed once in 0.7M 
sorbitol and then resuspended in an equivalent volume of 
extraction buffer. The cells were placed on ice for 10 
minutes and a weight of 0.3mm glass beads equal to that of 
the cells, was added. To disrupt the cells the handshake 
method was employed. This involved shaking the tubes 
containing the cells and glass beads for two minutes at 4°C 
by hand. This was followed by a period of one minute on ice.
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The cycle was repeated three times before the beads and cell 
debris were spun down by two consecutive spins at 4°C in a 
Sorvall SS34 rotor at 4000rpm. The supernatent was kept on 
ice then spun at lOOOOrpm for 20 minutes. The resultant 
pellet was resuspended in a minimal amount of extraction 
buffer. Protein concentration was determined by use of the 
Biuret assay (Gornall et al 1949).
Extraction Buffer 
0.1M Tris-HCl pH 8.0 
0.7M Sorbitol 
ImM EDTA pH 8.0 
2% BSA
3.2.6 Measurement of Membrane Potential by Fluorescence 
Assay (Based on Mewes and Rafael 1981)
The proton gradient across the inner membrane of
mitochondria was measured by the change in fluorescence 
between coupled mitochondria and uncoupled mitochondria. 
Mitochondria prepared as described above were placed in a 
cuvette containing 2.8ml of extraction buffer and 2pl of ImM 
DSMP'*' . Any fluorescence measured at this stage was due to 
simple diffusion of DSMP'*'. The addition of a substrate such 
as NADH causes DSMP* to pass into the matrix of the 
mitochondria where it fluoresces. To neutralize the membrane 
potential, and hence measure the difference between coupled 
and uncoupled mitochondria, an uncoupler CCCP was added (lpl 
of a ImM solution). Fluorescence was measured at 589 nm
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3.3 Results
3.3.1 Brewing Trials with alpha-cyano-4-hydroxycinnamic acid 
and the Mutant tpyl
In order to establish what concentration of inhibitor to use 
it was first necessary to titrate cell growth against 
different concentrations of the inhibitor. To do this cells 
were incubated with gentle shaking in YPD media containing 
concentrations of inhibitor between 1 and 50 mM. The cell 
concentration was estimated using a haemocytometer. The 
results are shown in table 3.3.1 and figure 3.3.1 
From these results the concentration of 15 mM was taken as 
being the optimum level and was used in subsequent brewing 
trials
A number of brewing trials were carried out using the 
inhibitor and a control. Trials were carried out using 
either 100 ml or 500 ml of wort. The results obtained are 
shown in table 3.3.2 and in figures 3.3.2 and 3.3.3. An 
extended brewing trial involving the inhibitor and a control 
was carried out over a period of 120 rather than 72 hours, 
the results are shown in table 3.3.4 and figure 3.3.5. 
Brewing trials were carried out using the mutant tpyl and 
the wild type X2180-1A. Trials were carried out using 100ml 
of artificial wort. The results are shown in table 3.3.3 and 
in figures 3.3.3 and 3.3.4
Table 3.3.1
THis shows the results of a brewing trial carried out 
with the inhibitor alpha-cyano-4-hydroxycinnamic acid 
against a control. The inhibitor was dissolved in DMSO 
and used in the brew at a final concentration of 15mM. 
The equivalent amount of DMSO was addedto the control. 
The yeast employed was an industrial ale yeast. These 
were large scale (500 ml) fermentations carried out over 
a period of 72 hours. Gravity of beer is a measure of 
the liquid density compared to water which is 1000. The 
ethanol content was estimated from a calibration curve 
of various concentrations from 1 to 5 X. Units of sugar 
are the difference between the original gravity and the 
gravity at the various times. The values of cells/unit 
sugar are given in terms of 100 ml of beer to allow 
comparison with the 100 ml scale fermentations shown 
later (See section 3.2.2 for further details).
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Brewing Trials with alpha-cyano-4-hydroxycinnamic acid
Time (hours)
0 24 48 72
Gravity
of
Inhibitor 1038 1021 1009 1008
Beer Control 1038 1008 1003 1002
Time (hours)
24 48 72
X Ethanol Inhibitor 0.65 2.69 3.17
in ♦/-0.07 ♦/-0.12 ♦/-0.05
Beer Control 1.24 3.45 3.65
♦7-0.07 ♦/-0.02 ♦/-0.05
Time (hours)
72
Wet Inhibitor 11.45
Weight 
of Yeast Control 16.5
(8)
Time (hours)
24 48 72
X Ethanol Inhibitor 0.038 0.093 0.106
/unit ♦/-0.004 ♦/-0.004 ♦/-0.002
sugar Control 0.041 0.099 0.101
♦/-0.002 ♦/-0.001 ♦/-0.002
Time (hours) 
72
Cells (g) Inhibitor 0.076
/unit
sugar Control 0.092
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with TPYl against the Wild Type
Time (hours)
0 24 48 72
Gravity
of
Beer
TPY1 1022 1018 1009 1007
WT 1022 1014 1006 1006
Time (hours)
24 48 72
X Ethanol TPYl 0.12 1.81 2.16
in «/-0.062 +/-0.075 ♦/-0.075
WT 0.58 2.10 2.10
«/-0.030 «7-0.075 ♦/-0.075
Time (hours) 
72
Wet TPYl 1.05
Weight 
of Yeast WT 1.20
(«)
Time (hours)
24 48 72
X Ethanol TPYl 0.030 0.14 0.14
/unit «7-0.015 «7-0.005 ♦/-0.005
sugar WT 0.072 0.13 0.13
«7-0.004 «/-0.005 ♦/-0.005
Time (hours) 
72
Cells (g) TPYl 0.070
/unit
sugar WT 0.075
Figure Graph representing the titration of cell growth against 
levels of alpha-cyano-4-hydroxycinnamic acid. The 
control contains an equivalent amount of the solvent 
DMSO used to dissolve the inhibitor in. The growth media 
was YPD. Cell density was measured after 24 hours using 
a haemocytometer.
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Graph representing total ethanol produced per total 
units of sugar used over 72 hours. Brewing trial 
involved alpha-cyano-4-hydroxycinnamic acid against a 
control. A unit of sugar is defined as a drop of one 
degree in gravity (See table 3.3.1 for further details).
Figure 3.3.2
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Graphs representing biomass formed per unit sugar used 
at 72 hours. Both brewing trials involoving alpha-cyano- 
4-hydroxycinnamic acid and the tpyl mutant are shown 
(See tables 3.3.1 and 3.3.2 for further details).
Figure 3.3.3

Figure Graph representing total ethanol produced per total 
units of sugar used over 72 hours. Brewing trial 
involved the tpyl mutant and the wild type. A unit of 
sugar is defined as a drop of one degree in gravity (See 
table 3.3.2 for further details).
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Figure 3.
Graph of an extended brewing trial using alpha-cyano-4- 
hydroxycinnaraic acid against a control. The inhibitor 
was dissolved in DMSO and added to wort to give a final 
concentration of 15mM. An equivalent amount of DMSO was 
added to the control. Brewing was carried out at 
temperatures between 18-22°C.
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3.3.2 Estimation of Mitochondrial Membrane Potential and 
Growth Pattern of the tpyl Mutant
The membrane potential of isolated mitochondria from both 
tpyl and the wild type was estimated using the substrates 
pyruvate/malate and NADH. Protein content of the 
mitochondrial preparations was estimated by the biuret 
method. The results obtained are shown in figure 3.3.6.
The tpyl mutant was unable to grow on YPE solid media. It 
was able to grow on YPE after being crossed with a rho°.
Piguce 3.3.6
Measurement of membrane potential using the substrates 
A) pyruvate/malate and B) NADH. Mitochondria were 
isolated from the wild type (WT) X2180-1A and the mutant 
(MT) tpyl strains of S .cerevisiae. Protein content was 
80mg/ml for WT and 30mg/ml for MT. 20ul of mitochondrial 
suspension was used for each assay. The uncoupler used 
was CCCP. Addition of a second 20ul aliquot of 
mitochondrial suspension to the cuvette containing the 
mutant mitochondria, did not alter the decrease in 
fluoresence upon addition of the uncoupler. The solid 
line represents the addition of mitochondria, DSMP+ and 
substrate. The dashed line represents the addition of 
uncoupler (CCCP).
FLUORESCENCE 
^
—
 FLUORESCENCE
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3.4 Discussion
3.4.1 Estimation of Mitochondrial Membrane Potential and 
Growth Pattern of the tpyl Mutant
Testing of tpyl mitochondria against X2180-1A revealed 
results differing from those reported by Wills and co­
workers (1986) Although mitochondria isolated from tpyl were 
unable to produce a membrane potential using 
pyruvate/malate, as reported by the authors, the 
mitochondria were also unable to generate a membrane 
potential with NADH, contrary to the authors report. The 
wild type mitochondria were able to generate a membrane 
potential with both substrates.
It is possible that mitochondria isolated from the tpyl 
mutant were not coupled. A number of attempts were made to 
isolate coupled mitochondria from the mutant and the wild 
type and only once was this possible. In correspondence with 
Professor Wills he stated that mitochondria isolated from 
this mutant were often "unhealthy".
Growth was not observed on 2X ethanol although the authors 
of the above mentioned paper did observe this. Growth of the 
tpyl mutant, after crossing with a rho°, on YPE was 
possible. This indicates that the tpyl mutation causing the 
phenotype is a nuclear mutation and not a deletion in the 
mitochondrial genome.
The type of mutation described by these results is more 
typical of a classical petite mutation rather than a
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mutation in a regulatory gene as described by Wills et al 
(1986).
More investigation is required if the true nature of the 
mutant is to be discovered.
3.4.2 Brewing Trials with alpha-cyano-4-hydroxycinnamic acid 
and a control
From brewing trials using an ale type yeast in the presence 
and absence of the inhibitor, it can be seen that the amount 
of ethanol formed, in terms of sugar utilized, is greater in 
the presence of the inhibitor . This is consistent with the 
the theory that blocking the route to the mitochondria may 
cause pyruvate to be diverted into the fermentation route. 
In the control experiment the yeast appear to utilize the 
vast majority of the available sugar in the first 48 hours 
and the rate of ethanol production is linear up to this 
point. The difference in the ethanol production between 
inhibited and control yeast is counterbalanced by the 
biomasa of cells produced per unit sugar . At 72 hours the 
amount of cells produced per unit sugar by the inhibited 
yeast is less than that of the control yeast.
If the 72 hour results were taken on their own then there is 
a possibility that the difference in levels of ethanol could 
be due to ethanol utilization by the control yeast as 
observed by Alexander and Detroy (1983). However the method 
of estimating ethanol concentration every 24 hours 
eliminates this possibility.
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From table 3.3.1 it can be seen that the inhibited yeast 
used considerably less sugar than the control. The reason 
for this difference could be a combination of slow growth 
and an inability to uptake sugars. Firstly there is the 
possibility that because the cells are growing slowly (due 
to changes in mitochondrial function) they are simply taking 
sugars up at a slower rate.However this seems an unlikely 
explanation as even with extended fermentations (figure 
3.3.5) the inhibited yeast is unable to use all the 
available sugar. Secondly, in the inhibited yeast there will 
be lower levels of intracellular ATP because production via 
oxidative phosphorylation will be virtually zero. This may 
lead to a decrease in the proton gradient across the plasma 
membrane. Since the principle sugar in wort, maltose, is 
taken up by proton symport a drop in the plasma membrane 
proton gradient could reduce the amount of this sugar taken 
up. The third possibility is that the mitochondria are 
directly affecting nuclear genes such as those coding for 
permeases. This type of phenomena has already been observed 
by Khan and Greener (1977). They found that deletions in the 
mitochondrial DNA affected the yeast cells ability to grow 
on maltose even though the grande parental strain was able 
to utilize maltose. Other petltes. unable to utilize alpha 
methylglucoside, were able to after treatment with 
dimethylsulphoxide (DMSO), which makes the plasma membrane 
'leaky' to large molecules (Mahler and Wilkie 1978). This 
suggests the problem with petites is that permease genes are
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repressed. It is not yet clear how the mitochondria affects 
the nuclear genes.
3.4.3 Brewing Trials with the Mutant TPY1 and the Wild Type 
From the brewing trials of tpyl against the wild type it can 
be seen that the mutant produces the same or possibly 
slightly more ethanol compared with the wild type after 72 
hours fermentation.
Since glucose is the only sugar present in the synthetic 
wort the difference in sugar utilization cannot be due to 
problems with uptake. Indeed the mutant is eventually able 
to utilize almost as much sugar as the wild type.
This experiment demonstrates a problem that may arise if a 
petite yeast were used in commercial brewing. There appears 
to be a critical density of cells required before 
fermentation accelerates to its peak. Thus the slower growth 
rate of petltes means they take longer to reach this 
density. The solution may simply lie in pitching 
(introducing cells to wort) at a higher density if the yeast 
is of a petite nature.
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CHAPTER 4
Cloning and Sequencing of a Gene Complerneting the tpyl 
Mutation
4.1 Introduction
From the results in chapter 3 it would appear that the 
mutation tpyl may be advantageous in a brewing yeast. In 
order to introduce this mutation it is first necessary to 
clone the gene that is mutated in the TPYl yeast. This can 
be carried out by complementation of the mutation with a 
gene contained in a genomic library of S.cerevisjae.
Once cloned the gene can be sequenced to try and establish 
its true nature. During the sequencing it will be possible 
to establish a unique site within the gene that may be used 
as a site for insertion of the G418 resistance gene.
The nature of the gene itself is of Interest. In the 
original paper describing the mutation the authors suggested 
the mutation may be in the RAS2 gene (Wills et al 1986). 
Yeast mutants in this gene have been shown to have a reduced 
ability to grow on pyruvate .
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Materials and Methods
4.2.1 DNA vectors
The multicopy plasmid Yepl3 containing S.cerevlsiae genomic 
library (Nasmyth and Reed 1980) was supplied by the 
Leicester Biocentre. The low copy plasmid Ycp50 containing 
S.cerevisiae genomic library was supplied by Princeton 
University. The plasmids M13mpl8 and M13mpl9 were supplied 
by Boehringer-Mannhiem.
4.2.2 Transformation of Yeast (Based on Beggs 1978)
Because of the high number of transformants required for the 
cloning of a gene from a library, the lithium acetate method 
of yeast transformation was inadequate and the spheroplast 
method was used instead.
Cells were grown to 1-2 x 10^/ml, as previously described, 
and were then harvested in a bench centrifuge. After washing 
with 1M sorbitol the cells were placed in 1M sorbitol 
containing lOmg/ml zymolyase 6000 and lpl/ml 2- 
mercaptoethanol and incubated at 30°C. Cells were observed 
under a microscope every 15 minutes. When the cells began to 
lyse in water they were presumed to have formed spheroplasts 
and were washed gently three times with 1M sorbitol. The 
cells were finally resuspended in 1ml of 1M sorbitol and 
lOOul of this was added to plasmid DNA. After 20 minutes at 
room temperature 1ml of 40X PEG 4000 was added to each
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transformation mix. After a further 20 minutes at room 
temperature the cells were heat shocked for 5 minutes at 
42°C. Following two washes in 1M sorbitol cells were placed 
in molten regeneration agar which was then placed on plates 
containing set regeneration agar and incubated at 30°C for 
4-6 days. When colonies had grown they could be removed with 
a toothpick and transferred to other plates for further 
testing.
Regeneration Agar 
2% Glucose
0.7X Yeast Nitrogen Base Without Amino Acids 
1M Sorbitol
20mg/l Uracil, Adenine, and Tryptophan 
2X Agar
4.2.3 Small Scale Plasmid Isolation from S.cerevisiae 
(Based on Hoffman et al 1986)
Yeast cells containing a plasmid were grown up overnight in 
selective media. From this culture 3ml were harvested by two 
high speed spins in a microfuge. The pellet was resuspended 
in the residual liquid and then 200^il of lysis solution, 
200pl of phenol/chloroform and 0.3g of sterile glass beads 
were added. The mixture was vortexed for 2 minutes and then 
spun for 5 minutes. The aqueous phase was removed and 
phenol/chloroform treated. After ethanol precipitation and 
vacuum drying the pellet was resuspended in 20^ il of TE.
Lysis Buffer 
2% Triton X-100 
IX SDS 
lOOmM NaCl 
lOraM Tris pH 8.0 
ImM EDTA pH 8.0
4.2.4 Transformation of Escherichia coli with M13 DNA. 
Transformations using plasmids derived from M13 
bacteriophage DNA were carried out essentially as desribed 
in chapter 2, with double-stranded or single-stranded 
plasmid, except that:
-30Qpl of competent cells were used.
-After heat-shock, Eppendorfs were placed on ice for 5 
minutes then 2.8 mis of lawn mix were added. Samples were 
then transferred into 3mls of H-top maintained at 45°C, 
mixed quickly and poured onto pre-warmed H-agar plates. When 
the H-top had set, the plates were inverted and incubated 
overnight at 37°C. Plaques were stored on the plates at 4°C 
and used within 48 hours for preparation of DNA.
H-Top. H-Agar.
IX (w/v) Bacto-Tryptone IX (w/v) Bacto-Tryptone
0.8X (w/v) NaCl 0.8X (w/v) NaCl
0.7X (w/v) Agar 1.5X (w/v) Agar
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2xTY Lawn Mix.
2X Bacto-Tryptone 
IX Yeast Extract grown overnight in 2xTY 
400^1 lOOmM IPTG 
400^1 lOOmM XGAL
2ml E.coli culture
0.5X NaCl
4.2.5 Single-Stranded DNA Preparation.
All steps were carried out at room temperature unless 
otherwise stated. Plaques were picked from H-top agar using 
sterile Pasteur pipettes and transferred to 3ml of 2xTY 
containing 30ul of an overnight E.coli culture. After
incubation at 37°C in an orbital shaker at 300rpm for 5 
hours, the cells were spun down at 2000g in a bench-top 
centrifuge leaving phage particles in the supernatant. 
1.5ml of supernatant was transferred to an Eppendorf and 
spun at high speed in a Eppendorf centrifuge. If a cell 
pellet was visible, the supernatant was transferred to a 
clean Eppendorf and respun. 1ml of supernatant was 
transferred to a clean Eppendorf and 200/a1 of PEG/NaCl
solution (20X w/v polyethylene glycol 6000/2.5M NaCl, 
autoclaved) were added. The tube was shaken and then left to 
stand for 15 minutes. Phage was precipitated by spinning in 
an Eppendorf centrifuge at high speed for 5 minutes. The 
supernatant was removed and the pellets respun for 3
minutes. Care was taken to remove any remaining supernatant, 
then the viral pellet was resuspended in lOOul TE. The
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sample was phenol/chloroform extracted, ethanol precipitated 
and then resuspended in 30^1 of TE or SDW.
4.2.6 DNA Sequencing.
Dideoxy Sequencing with Modified T7 DNA Polymerase. 
Sequencing was carried out by the dideoxy chain termination 
method (Sanger et_ al^  1977) using a Sequenase™ DNA 
sequencing kit from United States Biochemical Corporation. 
The chain termination method for sequencing involves 
synthesis of a DNA strand by DNA polymerase in vitro using a 
single-stranded DNA template. A synthetic oligonucleotide, 
complementary to a portion of the DNA template, is annealed 
to the template and the DNA polymerase initiates synthesis 
from this of a complementary strand. The primer is extended 
using dCTP, dGTP, dTTP and radioactively labeled [alpha-^S] 
dATP. The synthesis reaction is terminated by random 
incorporation of dideoxynucleotides triphosphates (ddNTPs) 
which are nucleotide analogues which lack the 3'-OH required 
for DNA chain elongation .
Sequenase™ is a modified form of bacteriophage T7 DNA 
polymerase (Tabor and Richardson 1987) which has low 3' to 
5' exonuclease activity and, unlike Klenow fragment, has 
high processivity therefore DNA strands elongating from the 
template terminate only when a dideoxynucleotide is 
incoporated.
Sequencing Ml3 Single-Stranded DNA Templates.
Single-stranded M13 DNA was prepared as in 4.2.5.
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Annealing of the primer to the template was carried out by 
adding lpl (0.5 pmoles/pl) of M13 universal primer and 2pl 
of 5xSequenase™ buffer (200mM Tri.-Cl pH7.5/100mM MgCl2/ 
250mM NaCl) to 2pg of DNA template in 7pl SDW, heating to 
65°C for 2 minutes then allowing the sample to cool to room 
temperature. The labelling reaction was carried out
according to the manufacturer's instructions by adding lpl 
0.1M DTT, 2pl diluted labelling mix , 0.5 pi [alpha 35S]dATP 
(lOuCi/ul Amersham International ) and 2pl diluted 
Sequenase™, followed by incubation at room temperature for 
5 minutes. For each sequencing reaction, a set of four 
Eppendorfs, labelled A,C,G and T, were pre-warmed to 37°C 
each containing 2.5pl of ddATP, ddCTP ddGTP, ddTTP
termination mixes respectively. When the labelling reaction 
was complete, 2.5 pi of the sample was transferred to each 
termination mix and the incubation continued at 37°C for a 
further 5 minutes. 4pl of stop solution (95X (v/v)
formamide/20mM EDTA/0.05X (w/v) Bromophenol Blue/0.05X (w/v) 
Xylene Cyanol) were then added to each Eppendorf and the 
samples stored at -20°C. Half of each sample was run on a 
sequencing gel (Section 4.2.7). Just before loading onto the 
sequencing gel, samples were heated to 80°C for 2 minutes. 
Sequencing Double-Stranded Plasmid DNA Templates.
Dideoxy sequencing can be readily performed on a double- 
stranded, closed circular DNA template that has been 
denatured with alkali (Chen and Seeburg 1985).
To 2pg of DNA in a total volume of 9/il (made up with SDW),
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lpl of 2M Na0H/0.02M EDTA was added and the sample incubated 
at room temperature for 5 minutes. The sample was then 
neutralised by the addition of 5jil 1M sodium acetate pH4.5 
and ethanol precipitated by the addition of 40jil cold 100% 
(v/v) ethanol and placing on dry ice for 15 minutes. The 
sample was then spun at high speed in an Eppendorf 
centrifuge for 10 minutes at 4°C, the supernatant removed 
and the pellet dried under vacuum. The pellet was then 
resuspended in 7;ul SDW; lpl primer (0.5pmoles/;il) and 2/il 5x 
Sequenase™ buffer were added and sequencing carried out 
using the Sequenase™ kit as above.
4.2.7 Preparation and Running of Sequencing Gels.
Sequencing gels are high-resolution polyacrylamide gels 
which are used to fractionate radiolabelled single-stranded 
oligonucleotides on the basis of size. To reduce the effects 
of DNA secondary structure on electrophoretic mobility, gels 
contain 7M urea and are run at sufficient voltage to heat 
them to approximately 65°C.
Sequencing gel plates (49.8cmxl9.8cmx0.5cm) were cleaned 
thoroughly and wiped with ethanol. The cuspid plate had 
Repelcote™ applied according to the manufacturer's 
instructions, then plates were assembled using 0.4mm 
spacers. A 6% sequencing gel was prepared by mixing 42ml of 
6% acrylamide mix with 252ul 10% (w/v) ammonium persulphate 
and llul TEMED. The gel was poured immediately by sucking 
the mixture into a 60ml syringe then slowly squirting it
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between the platea, avoiding trapping air bubbles. A shark- 
tooth comb 0.4mm thick, was inserted upside down 1cm into 
the top of the gel to create a well, and the gel left to 
polymerise at room temperature for 1 hour. Once polymerised, 
the comb and bottom spacer were removed and the exposed 
surfaces rinsed with distilled water. The gel was secured 
into the sequencing gel tank (BRL). The bottom reservoir was 
filled with lxTBE and the top reservoir with 0.5xTBE. The 
buffer was squirted between the plates at the bottom of the 
gel to remove air bubbles. The gel was pre-warmed by running 
at 45V/cm until hot to the touch. Just before loading the 
gel, the comb-well was rinsed by squirting buffer into it 
then the shark-tooth comb was inserted the correct way up 
with the points just sticking into the gel. After the 
samples were loaded, the gel was run at 45V/cm for 1.5 hours 
(until the bromophenol blue dye in the sequencing stop 
solution was at the bottom of the gel). When a sequence of 
over 200 bases needed to be read, half the sample was loaded 
and the gel run for approximately 90 minutes then the other 
half loaded and the gel run for a further 90 minutes.
After running, the plate treated with Repelcote™ was 
removed and the plate with the gel attached, submerged in 
gel fix for 15-20 minutes. The gel, still on the plate, was 
carefully removed from the gel fix. A piece of Whatman 3MM 
paper, slightly bigger than the gel, was laid on top of the 
gel then gently peeled off with the gel attached. The gel 
was dried onto the paper, under vacuum for 45 minutes at
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80°C. When dry, the gel was exposed to X-ray film (Fuji 
35.6cmx43.2cm Medical) overnight. The film was developed in 
a dark-room using LX24 developer (Kodak) and fixed with
Unifix1" (Kodak) according 
instructions.
6% Acrylamide Mix 
43g Urea 
5ml lOxTBE
15ml 40% Acrylamide mix 
Made up to 100ml with SDW 
Gel Fix.
10% (v/v) Acetic acid 
12% (v/v) Methanol
to the manufacturer's
40% Acrylamide Mix.
38% (w/v) Acrylamide 
2% (w/v) Bis-acrylamide 
(Made up with SDW)
4.2.8 Reading Sequencing Gels
Reading of gels was carried out using the Beckman Micro- 
Genie computer programme. The photograph of the gel was read 
via a digitiser onto floppy disc. Analysis such as 
restriction enzyme sites and discovery of open reading 
frames could then carried using the package
4.2.9 Analysis of Sequences
The sequence was further analyzed by use of the UWGCG 
package of sequencing programs available on the Daresbury 
network (Devereux et al 1984). As well as doing analysis 
such as hydrophobicity and translation the package enables a 
protein or DNA sequence to be compared against the latest
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Results
4.3.1 Cloning of a Gene Complementing the tpyl mutation 
Despite numerous attempts to clone the TPY1 gene using the 
multicopy library no colonies were obtained that were able 
to grow on glycerol using this genomic library. However one 
colony was obtained using the low copy library that was able 
to grow on glycerol. Plasmid DNA was extracted from the 
yeast cells able to grow on glycerol and was used to 
transform E.coli. A large scale preperation of plasmid DNA 
was carried out using E.coli able to grow on ampicillin 
plates. The plasmid DNA was used to transform the mutant 
strain of yeast TPY1 and colonies produced were all able to 
grow on glycerol. The plasmid was named pTPYlA
4.3.2 Restriction Mapping of TPY1 Gene
In order that the gene could be sequenced it was necessary 
to form a restriction map of the insert. Restriction enzymes 
used are shown in figure 4.3.1. The map of the gene formed 
from these digests is shown in figure 4.3.2.
4.3.3 Reducing the Size of the Complementing Fragment
In order that the gene could be sequenced it was also 
necessary to reduce the size of the fragment that contained 
the gene using restriction enzymes. This was accomplished as 
demonstrated in figure 4.3.3. The first change was to remove 
a 4kb fragment between the two EcoRI sites and ligate the
L 1 2 3 4 5 6 L
Figure
S.cerevisiae Genomic Library in Plasmid Ycp50
500  bp
I-----1
S3 XI Hill Cl 51 XI S I El Hill S3
S 3 = Sa u  3A X I=Xbo  I H III=Hlnd III C l= g a  I 
B I= BamH I S I= Sa l I E I=EcoR I
Figure 4.3.2
Plasmid Ycp50 containing fragments of S . cerevisiae 
genomic DNA. The library was constructed by ligation of 
fragments of a partial Sau3A digest of genomic DNA into 
the unique jJamill site in Ycp50. The insert shown in this 
figure is the one that complements the tpyl mutation. 
The shaded area represents the open reading frame 
discovered by the sequencing described in figure 
(plasmid map taken from Rose et al 198 7).
Figure 4.3.3
Complementation of the tpyl mutation by different 
fragments of the original insert contained in the YCp50 
genomic library. Only the major restriction sites 
contained in the area of interest are shown. The shaded 
area within the insert represents the open reading frame 
that complements the tpyl mutation.
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rest of the plasmid back together. This did not complement 
the mutation. The second change tried was to remove a 2kb 
fragment between the two Clal sites and ligating the rest of 
the plasmid back together. Again this did not complement the 
mutation. Next the 4kb EcoRI fragment was removed and 
ligated into the EcoRI site of Ycp50. This did complement 
the mutation. The fourth change was to remove the 2kb Clal 
fragment and ligate this into the Clal site of Ycp50. This 
did not complement the mutation. Finally a 2.7kb fragment 
between the Hindlll site and the EcoRI site was removed and 
cloned into Ycp50. This did not complement the mutation (See 
figure 4.3.2 for the restriction enzyme sites based in the 
plasmid).
These patterns suggested the gene was contained between the 
HindIII site and the Clal site, with more of the gene in the 
areas immediately adjacent to this fragment.
4.3.4 Sequencing Strategy
The sequencing strategy adopted was as shown figure 4.3.4. 
Four fragments were sequenced. The first was a 500bp 
fragment between the Xbal site and the Hindlll site. The 
second was a 700bp fragment between the same Hindlll site 
and the Clal site. Thirdly a 500bp fragment between the same 
Clal site and the BamHI site was sequenced. Finally a 300bp 
fragment between the BamHI and a Sail site was sequenced. 
The fragments were sequenced in both directions and overlaps 
were sequenced at the Hindlll. Clal and the BamHI sites.
Figure 4.3.4
The strategy for sequencing the TPY1 
was carried out with the 'Univers 
circular symbols are shown and 'eus 
where the square symbols are shown, 
within the insert represents the open 
compliments the tpyl mutation.
gene. Sequencing 
al' primer where 
tom made' primers 
The shaded area 
reading frame that
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4.3.5 Discovery of an Open Reading Frame
Computer analysis of the sequence showed an open reading 
frame beginning in the Sall-BamHI fragment and ending in the 
Hindlll-Xbal fragment. This satisfies the conditions laid 
out by the complementation experiments. No other open 
reading frames satisfied these conditions. The 2kb of DNA 
sequenced along with the protein translation of the open 
reading frame are shown in figure 4.3.5
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1610 1620 1630 1640 1650 1660 1670 1660 1690 1700 
TGÀÀTGÀAÀÀTGCCÀGGGAÀTTGGÀÀCÀÀÀTCÀÀÀCCCÀÀGÀTÀGCTTTÀCÀGGÀCÀAÀGÀÀÀTÀÀCGTCCGnCTCTCGÀAICTÀUCGÀGàGCÀÀCll 
euAsnGluAsnAlaArgGluLeuGluGliiIleLysProLysIleAlaLeuGlnAspLysGluIleThrSerValLeuSerisnLeulisGluSerAsnLy
1710 1720 1730 1740 1750 1760
AOGiTACCGTTTCnCJkiGàiÀATTlCTGAOGlCOCAGTTlUiOCIRAAATGUlOCilTG
1710 1790
TGMH
sArqTyrlr^tieFteLysLysIltStfGluispProValLysAlaLciUsaGliiCytlleilaSttnirSerAsBilaLeuLysVtlLeuSerGlyAsp
1110 1120 1130 1840 liso 1170 IMO 1190
CluGlyTyr AfBCl i AipOrtVilirq lrq lliAM fttfyityC lat— C l i i l i i rtUiArgC la ija llaaiyilIleLw SflM C lylr^ i
1.910_ 1920 1930 1940 1950 1960 197°
«t
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4.4 Discussion
The gene complementing the tpyl mutation has been cloned and 
sequenced. It is 1698 nucleotides long which code for a 
protein of 566 amino acids (approximately 62 kDa).
The open reading frame does not appear to be an exon of a 
larger sequence as the concensus splicing signals, GTATGT 
and TACTAAC, are not present (Teem et al 1984).
The predicted protein obtained from the nucleotide sequence 
would appear to be soluble rather than membrane bound. There 
are 72 acidic residues and 66 basic ones. There are no large 
domains of hydrophobicity (figure 4.4.1). The amino terminus 
of the protein was inspected for possible targeting activity 
as this is the area from which most mitochondrial nuclear 
encoded proteins are directed. The characteristic pattern 
normally associated with mitochondrial targeting is a large 
number of positively charged residues (lysine, arginine, 
serine and threonine) with few if any negatively charged 
residues. The TPY1 sequence contains 7 threonine and serine 
residues and 6 lysine and arginine residues in the the first 
25 amino acids. The sequence also contains an acidic residue 
aspartic acid at residue number 23. However this has been 
observed in previous targeting sequences (Ohmen et al 1988). 
Comparison with other DNA sequences revealed no similar 
sequence in the EMBL or Genbank DNA libraries. Comparison of 
the translated open reading frame with the Swissprot protein 
database revealed similarity with the FAS2 gene from
Figure 4.4.1
Hydrophobicity plot of the translated protein from the 
TPYl gene. Hydrophobicity is represented as the negative 
va lues .
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Figure 4.4.2
A comparison between the translated protein from the 
TPYlA gene and the FAS2 gene from Penici 11 ium patulum.
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Penicillium patulum (Figure 4.4.2). This gene codes for the 
enzyme complex fatty acid synthase, however the similarity 
would seem to be coincidental since there is less similarity 
between the FAS 2 of S.cerevisiae and the TPY1 gene, than 
there is between the FAS2 gene of P.patulum and the TPY1 
gene. There was no similarity to the RAS2 gene.
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CHAPTER 5
General Conclusion» and Discussion
5.1 Petite Yeasts and Fermentation
It appears from the experiments discussed In chapter 3 that 
petite and petite type mutations can be used to improve 
fermentation performance. Small, but commercially 
significant, increases in ethanol production per unit sugar 
have been shown with brewing trials using a chemical 
inhibitor and petite mutations in haploid yeast strains. 
Although there is little oxygen present in the brewing 
process the mitochondria obviously have some role to play. 
This can be seen from two facts. Firstly, as mentioned 
above, the petites produce more ethanol per unit sugar than 
their wild type counterparts. Secondly the petites produce 
less of their own biomass than the wild type. Thus although 
the mitochondria may not be respiratory functional during 
the brewing process, something about their condition affects 
the rest of the cell.
This type of regulation has been demonstrated before by 
Parikh and co-workers (1987, see introduction). The authors 
showed that abundance of some nuclear transcripts was 
affected by the condition of the mitochondrial genome. 
Although the petites reported in this thesis are nuclear 
they do affect the condition of the mitochondria. It may be 
that this is detected somehow by the cell and expression of 
enzymes involved in the fermentative pathway is enhanced. It
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has been found previously that levels of the key 
fermentative enzymes PDC and ADH were important in 
determining the rate of fermentation (Sharma and Tauro 
1986).
5.2 The Nature of the tpyl Mutation
If the work reported in this thesis were taken on its own, 
the tpyl mutation would probably be classified as a nuclear 
petite mutation. The inability of the mutant to grow on 
non-fermentable media, and the fact that isolated 
mitochondria are unable to produce a proton gradient in the 
presence of NADH, suggests this to be the case. However in 
the original paper describing the mutant (Hills et al 1986) 
and in correspondence with Professor Wills it is clear that 
the authors were able to isolate mitochondria that were 
capable of state 3 respiration.
The gene that complements the tpyl mutation is probably not 
a membrane bound transporter but a soluble protein targeted 
to the mitochondria. It has little similarity to the RAS2 
gene discussed as a possible site for the mutation in the 
original paper (Wills et al 1986). The only protein with 
which a significant amount of similarity was found was the 
FAS2 gene from Penicillium patulum( Weisner et al 1988). 
There was 18.3X identity or 58.3% similarity over 252 amino 
acids. The area of this gene that was similar to TPY1 has no 
specific function, although there was some overlap with the 
ketoacyl synthase domain of the FAS2 gene.
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5.3 Future Work
It is still not clear why petites and simulated petites 
(Chemically inhibited) use less sugar than their wild type 
counterparts, over the same period of time. They are pitched 
at the same cell density and, although there is some oxygen 
present in the wort at first, the respiratory competence of 
the wild type would not be enough to create the large 
differences in sugar utilization. One of the possible 
explanations, mentioned in chapter 3, was that uptake of a 
particular sugar could be responsible for the difference in 
sugar levels. This could be tested by examining the sugar 
profile at the end of a brewing trial. That is examine the 
proportions of sugars remaining after 72 hours of brewing. 
This could then be compared to proportions of sugars present 
at the start. Any sugar present in greater proportions at 
the end compared to the start could then be tested as a 
carbon source for the petites.
As mentioned earlier in this chapter it has been found that 
the quality and quantity of the mitochondrial genome can 
affect certain nuclear transcripts (Parikl et al 1987). 
Although the petites dealt with here are nuclear, their 
presence may cause damage to some obsolete mitochondrially 
coded genes. It would seem logical that if the mitochondria 
were damaged then the cell would detect this and try to 
increase the glycolytic flux. This could be achieved by 
increasing the levels of certain key enzymes. To try and 
detect such an increase of transcripts in petite cells,
probes could be made Co various key fermentation enzymes and 
levels compared with the wild type.
The nature of the tpyl mutant is still unknown. It appears 
to be targeted to the mitochondria but to be sure of this 
targeting experiments would have to be carried out.
To be certain that the cloned gene is the wild type form of 
the mutant, and not a suppressor of the mutation, the gene 
must be disrupted in another yeast (as described in chapter 
2). This is being carried out at present.
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APPENDIX 1
An Attempt to Transfer Mitochondria Between Industrial Yeast 
Strains
Al.l Introduction
It has been known for some time that certain strains of 
S.cerevisiae have advantages over others in terms of 
fermentative performance. In one case an increase in the 
rate of ethanol production was found to be linked with the 
intracellular levels of the key fermentation enzymes 
pyruvate decarboxylase and alcohol dehydrogenase (Sharma and 
Tauro, 1986). In another case the ethanol tolerance of wine 
yeasts appeared to be linked to the mitochondrial genome 
(Jimenez and Benitez, 1988).
In the lager type yeasts, formerly known as Saccharomyces 
calsbergenesis. the respiratory rate is particularly low 
compared with other brewing strains of S.cerevisiae. This 
suggests that fermentative rates may be higher in lager type 
yeasts than in other brewing yeasts. As respiration takes 
place in the mitochondria it may be possible to transfer 
this low respiratory capacity to another strain by transfer 
of the mitochondria. This may then lead to the strain with 
the lager type mitochondria possessing greater fermentative 
powers than before the transfer.
To transfer the mitochondria between two yeast strains 
requires the use of either hybridisation (Jimenez and 
Benitez, 1988) or spheroplast fusion (Ferenczy and Maraz 
1977), both of which are described in the main introduction.
104
In the case of Industrial yeasts, which are usually 
polyploid, spheroplast fusion must be used. To avoid nuclear 
fusion during transfer of mitochondria an intermediate 
strain of yeast is used as a carrier. The strain used must 
possess the mutation karl. Yeasts possessing this mutation 
are able to conjugate with other yeasts but there is no 
nuclear fusion (Conde and Fink, 1976). The technique of 
mitochondrial transfer involves fusion of the donor strain 
with a karl rho° yeast (ie a yeast strain with no functional 
mitochondrial genome). The receipt of the mitochondria is 
detected by the ability of the karl mutant to grow on a non- 
fermentable source such as glycerol. The karl rho* strain is 
then fused with the receiving yeast strain which is a rho° 
strain. The final strain is then selected by its ability to 
grow on glycerol. The process is described in figure A.1.1.
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Figure Al.l
Method of transfer of mitochondria between two 
industrial strains of yeast (for details see text).
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A1.2 Materials and Methods
Polyethylene glycol 4000 was supplied by BDH, Beta- 
glucuronidase was supplied by Boehringer-Mannhiem, all other 
reagents were of 'AnalR' grade.
Al.2.1 Yeast Strains
Ale Yeast Y9- Industrial strain supplied by Whitbread PLC. 
Lager Yeast Y7- Industrial strain supplied by Whitbread PLC. 
K5-5A rho°- Mat alpha. his4-15. ade2-l. cav-1 . karl-1 (Conde 
and Fink 1976), supplied by Whitbread PLC.
Al.2.2 Spheroplast Preparation (Based on Farahnak et al 
1986)
The treatment described below was carried out on the two 
strains to be fused.
Yeasts were grown in 10 ml of YPD media to stationary level. 
From these cultures 0.1 ml (strain dependent) were used to 
inoculate 10 ml of fresh YPD and these were incubated with 
aeration at 30°C overnight. Half of these cultures were 
pelleted by centrifugation in a bench centrifuge at 5000 
rpm. The pellets were washed in 2 ml of a 0.1M sodium 
acetate, pH 5.3, then resuspended in 2 ml of the same 
solution containing lOmM Beta-Mercaptoethanol. After 10 
minutes at room temperature the cells were washed twice in 
sodium acetate and finally resuspended in 0.8 ml of 
spheroplasting solution. After 40 minutes at 37°C the cells
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were checked for spheroplasting by placing the cells in 
water and microscopically observing the number of intact 
cells. If more than 90X of the cells burst they were assumed 
to be ready for fusion.
Spheroplasting Solution 
0.1M Sodium Acetate pH 5.3 
0.7M Sorbitol
20 pi Beta-Glucuronidase (10000 units/ml)
Al.2.3 Fusion of Spheroplasts (Based on Farahnak et al 1986) 
After spheroplasting treatment the cells were washed three 
times in washing solution (3000 rpm in a bench centrifuge). 
After the final wash the cells were pelleted together at 
3000 rpm. The cells were resuspended in residual fluid and 
then 1 ml of fusion solution was added.
After 20 minutes at 37°C the cells were diluted to 10"* and 
10"5 in washing solution. Aliquots of 0.2 ml were added to 
10 ml of regeneration agar (maintained at 45°C) and the 
mixture was poured onto plates containing set regeneration 
agar.
Washing Solution Fusion Solution
0.1M Sodium Acetate pH 5.3 0.1M Sodium Acetate pH 5.3
lOmM Calcium Chloride 50X PEG 4000
lOmM Calcium Chloride0.7M Sorbitol
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Al.2.4 Testing of Regeneration Products
After regeneration (4-6 days) colonies were removed from 
agar with a toothpick and placed on selective media.
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A1.3 Results
An attempt was made to introduce the mitochondria from a 
lager strain of yeast into an ale strain of yeast (as 
described in the introduction). However no transfer of 
mitochondria was observed at the first stage of transfer ie 
transfer of lager strain mitochondria into a karl mutant. 
Protoplasting and regeneration were demonstrated by controls 
in the above mentioned experiments. Spheroplast fusion was 
demonstrated by fusing two Mat alpha strains C2 and JRY188.
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Al,4 Discussion
The frequency with which mitochondria are supposed to 
transfer between two strains of yeast has been worked out to 
be, on average, 10"^ by one laboratory (Iserentart, personal 
communication). It may be that the fusion event did not take 
place at a high enough frequency to allow transfer of 
mitochondria.
Another possibility for the lack of success could be poor 
cytoplasmic mixing. During experiments carried out by Sena 
(Sena 1982), the author found that transfer of mitochondria 
from a karl mutant to a petite was proving difficult. The 
problem proved to be poor cytoplasmic mixing in the zygote. 
This could be the situation in the case of fusion between 
the lager strain and the karl petite.
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APPENDIX 2
Results and Discussion of Chapter 2
Preliminary brewing trials with the pet!22 mutant, suggest 
there is little difference in fermentation performance 
between it and the wild type yeast C2 (Table A2.1).
Why should it be that there are differences in fermentation 
performance between Inhibited yeast (inhibited with alpha- 
cyano-4-hydroxycinnamic acid) and uninhibited yeast, and the 
tpyl mutant and the wild type, but not the pet!22 mutant and 
its wild type?
The first possibility is that the change in performance goes 
unnoticed in this strain of yeast. The inhibitor trials were 
carried out with a polyploid brewing strain of yeast whereas 
the pet!22 brewing trials were carried out with a haploid 
laboratory strain which was able to utilize maltose. This 
strain has recently been shown to be unable to utilize 
maltotriose (Whitbread PLC, personal communication). If the 
difference in previous brewing trials were due to an
inability of the mutant/inhlbited yeast to utilize
maltotriose then this would not be apparent in a C2 brewing 
trial.
The second possibility is that the pet!22 mutation does not 
cause the same changes as those observed previously. The
mutation is effective at the cytochrome oxidase complex, the 
final complex in the chain of electron carriers. The
inhibitor and tpyl are both thought to work at the level of 
pyruvate transport into the mitochondria, although this
makes no real difference in terms of mitochondrial 
respiratory activity it may be that any signal telling the 
cell that the mitochondria are not active only occurs when 
certain parts of the respiratory chain are inactivated.
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Table A2.1.
THis shows Che results of a brewing trial carried out 
with the mutant pet 122 and the wild type C2. These were 
large scale (500 ml) fermentations carried out over a 
period of 144 hours at the Whitbread laboratories in 
Luton by Mr John Hossack. Gravity of beer is a measure 
of the liquid density compared to water which is 1000. 
The levels of ethanol were determined by Gas 
Chromatography.
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Brewing
Gravity
of
Beer
X Ethanol 
In
Beer
Hat
Weight 
of Yeast
(g)
X Ethanol 
/unit
sugar
Cells (g)
/unit
sugar
Trials with the pet!22 mutant and the Wild Type C2.
0
Time
24
(hours)
48 144
petl22 1051 1035 1029 1016
Wild Type 1051 1037 1028 1016
Time (hours) 
144
petl22 4.71
Wild Type 4.71
Time (hours) 
144
petl22 7.0
Wild Type 6.9
Time (hours) 
144
petl22 0.135
Wild Type 0.135
Time (hours) 
144
petl22 0.2
Wild Type 0.2
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